<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FVNNU="http://FVNNU/20260331"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fvnnu-20260331.xsd" xlink:type="simple"/>
    <context id="From2026-01-01to2026-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_UnitsEachConsistingOfOneOrdinaryShareAndOneRightToAcquire110Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:UnitsEachConsistingOfOneOrdinaryShareAndOneRightToAcquire110Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_OrdinarySharesIncludedAsPartOfUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:OrdinarySharesIncludedAsPartOfUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_RightsIncludedAsPartOfUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:RightsIncludedAsPartOfUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-04-012026-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-04-012026-06-30_custom_RedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FVNNU:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_RedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FVNNU:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_RedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FVNNU:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_RedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FVNNU:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-04-012026-06-30_custom_NonRedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FVNNU:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_NonRedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FVNNU:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_NonRedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FVNNU:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_NonRedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FVNNU:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-04-012026-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-04-012026-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-04-012026-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-09-012024-09-13_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-13</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-13_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-13</instant>
        </period>
    </context>
    <context id="AsOf2024-09-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <instant>2024-09-13</instant>
        </period>
    </context>
    <context id="From2024-09-012024-09-13_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-13</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-09-13_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-13</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-09-13_custom_RepresentativeSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:RepresentativeSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-13</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-13_custom_RepresentativeSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:RepresentativeSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-13</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <instant>2024-11-28</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2026-04-012026-06-30_custom_RedeemableOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:RedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-04-012026-06-30_custom_NonRedeemableOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:NonRedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_RedeemableOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:RedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_custom_NonRedeemableOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:NonRedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_RedeemableOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:RedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_NonRedeemableOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:NonRedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_RedeemableOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:RedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_NonRedeemableOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FVNNU:NonRedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-09-13_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-13</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_RepresentativeSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:RepresentativeSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2024-02-012024-02-27_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-27</endDate>
        </period>
    </context>
    <context id="From2024-02-012024-02-27_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-27</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <instant>2024-02-22</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_AdministrativeSupportServiceFeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">FVNNU:AdministrativeSupportServiceFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AdministrativeSupportServiceFeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">FVNNU:AdministrativeSupportServiceFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_PromissoryNoteForExtensionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">FVNNU:PromissoryNoteForExtensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PromissoryNoteForExtensionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">FVNNU:PromissoryNoteForExtensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-01-29_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-29</instant>
        </period>
    </context>
    <context id="From2024-01-012024-01-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-29</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-27_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-27</instant>
        </period>
    </context>
    <context id="From2024-09-012024-09-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-13</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:UnderwritersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_FounderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:FounderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_us-gaap_IPOMember_custom_RepresentativeSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FVNNU:RepresentativeSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-07-08_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002010653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-08</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2026-01-01to2026-06-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2026-01-01to2026-06-30" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2026-01-01to2026-06-30" id="Fact000005">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2026-01-01to2026-06-30" id="Fact000006">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2026-01-01to2026-06-30" id="Fact000007">0002010653</dei:EntityCentralIndexKey>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0059"
      unitRef="USD"
      xsi:nil="true"/>
    <FVNNU:PromissoryNoteRelatedParty
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0080"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2026-06-30"
      id="xdx2ixbrl0088"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0089"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2026-06-30"
      id="xdx2ixbrl0118"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0122"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2026-04-012026-06-30"
      id="xdx2ixbrl0175"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-04-012025-06-30"
      id="xdx2ixbrl0176"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0177"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0178"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="From2026-04-012026-06-30"
      id="xdx2ixbrl0185"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="From2025-04-012025-06-30"
      id="xdx2ixbrl0186"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0187"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0188"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0261"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0266"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0267"
      unitRef="USD"
      xsi:nil="true"/>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0271"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0278"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-04-012026-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-04-012026-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0284"
      unitRef="USD"
      xsi:nil="true"/>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2026-04-012026-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0288"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0294"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0302"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0308"
      unitRef="USD"
      xsi:nil="true"/>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0312"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0319"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0324"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-04-012025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0325"
      unitRef="USD"
      xsi:nil="true"/>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0336"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesRealizedGainLoss
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0372"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0378"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0380"
      unitRef="USD"
      xsi:nil="true"/>
    <FVNNU:AccretionOfRedeemableOrdinarySharesToRedemptionValue
      contextRef="From2026-04-012026-06-30_custom_NonRedeemableOrdinaryShareMember"
      id="xdx2ixbrl0585"
      unitRef="USD"
      xsi:nil="true"/>
    <FVNNU:AccretionOfRedeemableOrdinarySharesToRedemptionValue
      contextRef="From2025-04-012025-06-30_custom_NonRedeemableOrdinaryShareMember"
      id="xdx2ixbrl0587"
      unitRef="USD"
      xsi:nil="true"/>
    <FVNNU:AccretionOfRedeemableOrdinarySharesToRedemptionValue
      contextRef="From2026-01-012026-06-30_custom_NonRedeemableOrdinaryShareMember"
      id="xdx2ixbrl0647"
      unitRef="USD"
      xsi:nil="true"/>
    <FVNNU:AccretionOfRedeemableOrdinarySharesToRedemptionValue
      contextRef="From2025-01-012025-06-30_custom_NonRedeemableOrdinaryShareMember"
      id="xdx2ixbrl0649"
      unitRef="USD"
      xsi:nil="true"/>
    <FVNNU:DueToRelatedParties
      contextRef="AsOf2025-12-31_custom_PromissoryNoteForExtensionMember"
      id="xdx2ixbrl0792"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2026-01-01to2026-06-30" id="Fact000013">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2026-01-01to2026-06-30" id="Fact000014">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2026-01-01to2026-06-30" id="Fact000015">2026-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2026-01-01to2026-06-30" id="Fact000016">false</dei:DocumentTransitionReport>
    <dei:EntityRegistrantName contextRef="From2026-01-01to2026-06-30" id="Fact000017">FUTURE VISION II ACQUISITION CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2026-01-01to2026-06-30" id="Fact000018">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2026-01-01to2026-06-30" id="Fact000019">001-42273</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2026-01-01to2026-06-30" id="Fact000020">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2026-01-01to2026-06-30" id="Fact000021">Xiandai Tongxin Building</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2026-01-01to2026-06-30" id="Fact000022">201 Xin Jinqiao Road</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2026-01-01to2026-06-30" id="Fact000023">Rm 302</dei:EntityAddressAddressLine3>
    <FVNNU:EntityAddressAddressLine4 contextRef="From2026-01-01to2026-06-30" id="Fact000025">Pudong New District</FVNNU:EntityAddressAddressLine4>
    <dei:EntityAddressCityOrTown contextRef="From2026-01-01to2026-06-30" id="Fact000026">Shanghai</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2026-01-01to2026-06-30" id="Fact000027">CN</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="From2026-01-01to2026-06-30" id="Fact000028">00000</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2026-01-01to2026-06-30" id="Fact000029">86</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2026-01-01to2026-06-30" id="Fact000030">136 0300 0540</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="From2026-01-012026-06-30_custom_UnitsEachConsistingOfOneOrdinaryShareAndOneRightToAcquire110Member"
      id="Fact000031">Units, each consisting of one ordinary share and one right to acquire 1/10th of one Ordinary Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-01-012026-06-30_custom_UnitsEachConsistingOfOneOrdinaryShareAndOneRightToAcquire110Member"
      id="Fact000032">FVNNU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-01-012026-06-30_custom_UnitsEachConsistingOfOneOrdinaryShareAndOneRightToAcquire110Member"
      id="Fact000033">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2026-01-012026-06-30_custom_OrdinarySharesIncludedAsPartOfUnitsMember"
      id="Fact000034">Ordinary Shares included as part of the Units</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-01-012026-06-30_custom_OrdinarySharesIncludedAsPartOfUnitsMember"
      id="Fact000035">FVN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-01-012026-06-30_custom_OrdinarySharesIncludedAsPartOfUnitsMember"
      id="Fact000036">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2026-01-012026-06-30_custom_RightsIncludedAsPartOfUnitsMember"
      id="Fact000037">Rights included as part of the Units</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-01-012026-06-30_custom_RightsIncludedAsPartOfUnitsMember"
      id="Fact000038">FVNNR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-01-012026-06-30_custom_RightsIncludedAsPartOfUnitsMember"
      id="Fact000039">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="From2026-01-01to2026-06-30" id="Fact000040">No</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2026-01-01to2026-06-30" id="Fact000041">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2026-01-01to2026-06-30" id="Fact000042">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2026-01-01to2026-06-30" id="Fact000043">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2026-01-01to2026-06-30" id="Fact000044">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2026-01-01to2026-06-30" id="Fact000045">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="From2026-01-01to2026-06-30" id="Fact000046">true</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000047"
      unitRef="Shares">7544000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000055"
      unitRef="USD">788401</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000056"
      unitRef="USD">1024709</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000058"
      unitRef="USD">44232</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:MarketableSecurities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000061"
      unitRef="USD">62882640</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000062"
      unitRef="USD">61035590</us-gaap:MarketableSecurities>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000064"
      unitRef="USD">63715273</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000065"
      unitRef="USD">62060299</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000067"
      unitRef="USD">63715273</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000068"
      unitRef="USD">62060299</us-gaap:Assets>
    <FVNNU:DueToRelatedParties
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000076"
      unitRef="USD">218333</FVNNU:DueToRelatedParties>
    <FVNNU:DueToRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000077"
      unitRef="USD">158000</FVNNU:DueToRelatedParties>
    <FVNNU:PromissoryNoteRelatedParty
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000079"
      unitRef="USD">765900</FVNNU:PromissoryNoteRelatedParty>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000082"
      unitRef="USD">984233</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000083"
      unitRef="USD">158000</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000085"
      unitRef="USD">984233</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000086"
      unitRef="USD">158000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000093"
      unitRef="Shares">5750000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000094"
      unitRef="Shares">5750000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000091"
      unitRef="USD">62882640</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000092"
      unitRef="USD">60097778</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000102"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000104"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000106"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000108"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000110"
      unitRef="Shares">1794000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000112"
      unitRef="Shares">1794000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000114"
      unitRef="Shares">1794000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000116"
      unitRef="Shares">1794000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000099"
      unitRef="USD">179</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000100"
      unitRef="USD">179</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000119"
      unitRef="USD">1804342</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000121"
      unitRef="USD">-151779</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000124"
      unitRef="USD">-151600</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000125"
      unitRef="USD">1804521</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000127"
      unitRef="USD">63715273</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000128"
      unitRef="USD">62060299</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000130"
      unitRef="USD">109436</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000131"
      unitRef="USD">40504</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000132"
      unitRef="USD">200639</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000133"
      unitRef="USD">177404</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000135"
      unitRef="USD">30333</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000136"
      unitRef="USD">30333</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000137"
      unitRef="USD">60333</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000138"
      unitRef="USD">60333</us-gaap:AdministrativeFeesExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000140"
      unitRef="USD">139769</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000141"
      unitRef="USD">70837</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000142"
      unitRef="USD">260972</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000143"
      unitRef="USD">237737</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000145"
      unitRef="USD">-139769</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000146"
      unitRef="USD">-70837</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000147"
      unitRef="USD">-260972</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000148"
      unitRef="USD">-237737</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeOther
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000155"
      unitRef="USD">4115</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000156"
      unitRef="USD">8301</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000157"
      unitRef="USD">8563</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000158"
      unitRef="USD">17140</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000160"
      unitRef="USD">545639</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000161"
      unitRef="USD">614436</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000162"
      unitRef="USD">1081150</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000163"
      unitRef="USD">1226797</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherIncome
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000165"
      unitRef="USD">549754</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000166"
      unitRef="USD">622737</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000167"
      unitRef="USD">1089713</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000168"
      unitRef="USD">1243937</us-gaap:OtherIncome>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000170"
      unitRef="USD">409985</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000171"
      unitRef="USD">551900</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000172"
      unitRef="USD">828741</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000173"
      unitRef="USD">1006200</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000180"
      unitRef="USD">409985</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000181"
      unitRef="USD">551900</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000182"
      unitRef="USD">828741</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000183"
      unitRef="USD">1006200</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000190"
      unitRef="USD">409985</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000191"
      unitRef="USD">551900</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000192"
      unitRef="USD">828741</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000193"
      unitRef="USD">1006200</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-04-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000195"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-04-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000197"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-04-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000199"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-04-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000201"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-01-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000203"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-01-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000205"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000207"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-01-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000209"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-04-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000211"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-04-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000213"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-04-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000215"
      unitRef="USDPShares">0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-04-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000217"
      unitRef="USDPShares">0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-01-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000219"
      unitRef="USDPShares">0.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-01-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000221"
      unitRef="USDPShares">0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-01-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000223"
      unitRef="USDPShares">0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-01-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000225"
      unitRef="USDPShares">0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-04-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000227"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-04-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000229"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-04-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000231"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-04-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000233"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-01-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000235"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-01-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000237"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000239"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-01-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000241"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-04-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000243"
      unitRef="USDPShares">-0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-04-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000245"
      unitRef="USDPShares">-0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-04-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000247"
      unitRef="USDPShares">-0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-04-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000249"
      unitRef="USDPShares">-0.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-01-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000251"
      unitRef="USDPShares">-0.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-01-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000253"
      unitRef="USDPShares">-0.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-01-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000255"
      unitRef="USDPShares">-0.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-01-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000257"
      unitRef="USDPShares">-0.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000264"
      unitRef="Shares">1794000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000259"
      unitRef="USD">179</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000260"
      unitRef="USD">1804342</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000262"
      unitRef="USD">1804521</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000268"
      unitRef="USD">418756</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2026-01-012026-03-31"
      decimals="0"
      id="Fact000269"
      unitRef="USD">418756</us-gaap:ProfitLoss>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2026-01-012026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000272"
      unitRef="USD">-1246042</FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2026-01-012026-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000273"
      unitRef="USD">-418756</FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2026-01-012026-03-31"
      decimals="0"
      id="Fact000274"
      unitRef="USD">-1664798</FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000281"
      unitRef="Shares">1794000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000276"
      unitRef="USD">179</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000277"
      unitRef="USD">558300</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000279"
      unitRef="USD">558479</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2026-04-012026-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000285"
      unitRef="USD">409985</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000286"
      unitRef="USD">409985</us-gaap:ProfitLoss>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2026-04-012026-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000289"
      unitRef="USD">-558300</FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2026-04-012026-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000290"
      unitRef="USD">-561764</FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000291"
      unitRef="USD">-1120064</FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000298"
      unitRef="Shares">1794000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000293"
      unitRef="USD">179</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000295"
      unitRef="USD">-151779</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000296"
      unitRef="USD">-151600</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000305"
      unitRef="Shares">1794000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000300"
      unitRef="USD">179</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000301"
      unitRef="USD">7694028</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000303"
      unitRef="USD">7694207</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000309"
      unitRef="USD">454300</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact000310"
      unitRef="USD">454300</us-gaap:ProfitLoss>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000313"
      unitRef="USD">-646298</FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000314"
      unitRef="USD">-454300</FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2025-01-012025-03-31"
      decimals="0"
      id="Fact000315"
      unitRef="USD">-1100598</FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000322"
      unitRef="Shares">1794000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000317"
      unitRef="USD">179</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000318"
      unitRef="USD">7047730</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000320"
      unitRef="USD">7047909</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2025-04-012025-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000326"
      unitRef="USD">551900</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000327"
      unitRef="USD">551900</us-gaap:ProfitLoss>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2025-04-012025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000330"
      unitRef="USD">-2756823</FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2025-04-012025-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000331"
      unitRef="USD">-551900</FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue>
    <FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000332"
      unitRef="USD">-3308723</FVNNU:AccretionOfOrdinaryShareSubjectToRedemptionValue>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000339"
      unitRef="Shares">1794000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000334"
      unitRef="USD">179</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000335"
      unitRef="USD">4290907</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000337"
      unitRef="USD">4291086</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000344"
      unitRef="USD">828741</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000345"
      unitRef="USD">1006200</us-gaap:NetIncomeLoss>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000350"
      unitRef="USD">1081150</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000351"
      unitRef="USD">1226797</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000356"
      unitRef="USD">44232</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000357"
      unitRef="USD">40978</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000359"
      unitRef="USD">60333</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000360"
      unitRef="USD">60333</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000362"
      unitRef="USD">-236308</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000363"
      unitRef="USD">-201242</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:MarketableSecuritiesRealizedGainLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000368"
      unitRef="USD">765900</us-gaap:MarketableSecuritiesRealizedGainLoss>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000371"
      unitRef="USD">-765900</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000377"
      unitRef="USD">765900</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000381"
      unitRef="USD">16000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000383"
      unitRef="USD">765900</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000384"
      unitRef="USD">-16000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000386"
      unitRef="USD">-236308</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000387"
      unitRef="USD">-217242</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000389"
      unitRef="USD">1024709</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000390"
      unitRef="USD">1332505</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000392"
      unitRef="USD">788401</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000393"
      unitRef="USD">1115263</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <FVNNU:AccretionOfOrdinarySharesSubjectToRedemptionValue
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000398"
      unitRef="USD">2784862</FVNNU:AccretionOfOrdinarySharesSubjectToRedemptionValue>
    <FVNNU:AccretionOfOrdinarySharesSubjectToRedemptionValue
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000399"
      unitRef="USD">4409321</FVNNU:AccretionOfOrdinarySharesSubjectToRedemptionValue>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000401">&lt;p id="xdx_805_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zktMPwwDCiXg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 1 &#x2014; &lt;span id="xdx_82E_zaf8stdNeDf2"&gt;Organization and Business Operation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Future Vision II Acquisition Corp. (the &#x201c;Company&#x201d;) is a blank check company incorporated as a Cayman Islands exempted company on January&#160;30, 2024. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the &#x201c;Business Combination&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On November&#160;12, 2024, the Company formed a wholly-owned subsidiary, Future Vision II Acquisition Merger Subsidiary Corp. (the &#x201c;Merger Sub&#x201d;), which is an exempted company incorporated under the laws of the Cayman Islands, for the purpose of consummating a Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2026, the Company had not commenced any operations. All activities through June 30, 2026 have been limited to the Company&#x2019;s organizational activities as well as activities related to the Initial Public Offering (as defined below). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering and Private Placement (as defined below). The Company has selected December&#160;31 as its fiscal year end.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s founder and sponsor is HWei Super Speed Co. Ltd., a British Virgin Island business company with limited liability (the &#x201c;Sponsor&#x201d;). The registration statement for the Company&#x2019;s Initial Public Offering was declared effective on September&#160;11, 2024. On September&#160;13, 2024, the Company consummated its Initial Public Offering of &lt;span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240901__20240913__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember_zagHlQx9W0Jc"&gt;5,000,000 &lt;/span&gt;units (the &#x201c;Units&#x201d; and, with respect to the Ordinary Shares included in the Units being offered, the &#x201c;Public Shares&#x201d;), at $&lt;span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_c20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zq0AH23QPE4g"&gt;10.00 &lt;/span&gt;per Unit, generating gross proceeds of $&lt;span id="xdx_908_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20240901__20240913__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember_zI8ada0tXQTa"&gt;50,000,000 &lt;/span&gt;(the &#x201c;Initial Public Offering&#x201d;, or &#x201c;IPO&#x201d;), and incurring offering costs of $&lt;span id="xdx_907_eus-gaap--DeferredOfferingCosts_iI_c20240913_z25lO1wvxE1g"&gt;1,845,513&lt;/span&gt;. The Company granted the underwriter a 45-day option to purchase up to an additional &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240901__20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zBvrwR6xQ1Cj"&gt;750,000 &lt;/span&gt;Units at the Initial Public Offering price to cover over-allotments, if any. As of September&#160;13, 2024, the over-allotment option was exercised, generating gross proceeds of $&lt;span id="xdx_90F_eus-gaap--ProceedsFromStockOptionsExercised_c20240901__20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zhkztZo29q5h"&gt;7,500,000 &lt;/span&gt;and deposited into the Trust Account. Meanwhile, &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240901__20240913__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RepresentativeSharesMember_zMoYLGmT5Uti"&gt;57,500 &lt;/span&gt;ordinary shares were issued to the underwriter at the closing of the IPO as representative shares (the &#x201c;Representative Shares&#x201d;), and &lt;span id="xdx_90E_eus-gaap--SharesIssued_iI_c20240913__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RepresentativeSharesMember_zqhZSXuArFa5"&gt;28,750 &lt;/span&gt;representative shares will be issued as the deferred underwriting commission at the consummation of a Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Simultaneously with the consummation of the closing of the IPO, the Company consummated the private placement of an aggregate of &lt;span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zBZEM37VU42c"&gt;299,000 &lt;/span&gt;units (the &#x201c;Placement Units&#x201d;) to the Sponsor at a price of $&lt;span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z3SFZddxG3e7"&gt;10.00 &lt;/span&gt;per Unit, generating gross proceeds of $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zKERBUjeMSKf"&gt;2,990,000 &lt;/span&gt;(the &#x201c;Private Placement&#x201d;). (see Note 4).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s initial Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount held in trust) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires &lt;span id="xdx_905_ecustom--BusinessCombinationPercentageOfVotingSecurities_iI_dp_c20260630_zWiivfR1SqM5" title="Business combination percentage of voting securities"&gt;50&lt;/span&gt;% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target sufficient for the post-transaction company not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;). There is no assurance that the Company will be able to complete a Business Combination successfully.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Following the closing of the IPO on September&#160;13, 2024, an amount of $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20240901__20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zXmGJ1eXwsnc"&gt;57,500,000 &lt;/span&gt;($&lt;span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_c20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zKCf82CLMPtk"&gt;10.00 &lt;/span&gt;per Unit) from the net proceeds of the sale of the Units in the IPO and a portion of the proceeds from the sale of the Placement Units was placed in a trust account (&#x201c;Trust Account&#x201d;) and invested in U.S. government securities, within the meaning set forth in Section&#160;2(a)(16) of the Investment Company Act of 1940, with a maturity of 180 days or less, or in money market funds meeting certain conditions of Rule&#160;2a-7 of the Investment Company Act of 1940 which invest only in direct U.S. government treasury obligations, as determined by the Company. The proceeds from this offering held in the trust account will not be released from the trust account (1) to the Company, until the completion of the initial Business Combination, or (2) to public shareholders, until the earliest of: (a) the completion of the initial Business Combination, (b) the redemption of any ordinary shares sold as part of the units in this offering (the &#x201c;public shares&#x201d;) properly submitted in connection with a shareholder vote to amend the Company&#x2019;s second amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company&#x2019;s obligation to provide holders of the Company&#x2019;s ordinary shares the right to have their shares redeemed in connection with the Company&#x2019;s initial Business Combination or to redeem 100% of the Company&#x2019;s public shares if the Company does not complete the initial Business Combination by March&#160;13, 2026 (as extended to August&#160;13, 2026 pursuant to the First, Second, Third, Fourth and Fifth Extension defined below) or up to September&#160;13, 2026 (an &#x201c;Extension Period&#x201d;) or (B) with respect to any other provision relating to the rights of holders of the Company&#x2019;s ordinary shares, and (c) the redemption of the Company&#x2019;s public shares if it has not consummated the Business Combination within 18 months from the closing of this offering or during any Extension Period, subject to applicable law. Public shareholders who redeem their ordinary shares in connection with a shareholder vote described in clause (b) in the preceding sentence shall not be entitled to funds from the trust account upon the subsequent completion of an initial Business Combination or liquidation if the Company has not consummated an initial Business Combination within 18 months from the closing of this offering, with respect to such ordinary shares so redeemed. The proceeds deposited in the trust account could become subject to the claims of the Company&#x2019;s creditors, if any, which could have priority over the claims of the Company&#x2019;s public shareholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.05 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter. The ordinary shares subject to redemption is recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $&lt;span id="xdx_900_ecustom--NetTangibleAssets_iI_c20260630_zishjx5cfeV1" title="Net tangible assets"&gt;5,000,001 &lt;/span&gt;upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company will have only 18 months from the closing of the Initial Public Offering or during any Extension Period to complete the initial Business Combination (the &#x201c;Combination Period&#x201d;). If the Company is unable to complete the initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company for working capital purposes or to pay the Company&#x2019;s taxes (less up to $&lt;span id="xdx_90C_ecustom--DissolutionExpenses_c20260101__20260630_zDJ2E3tlYRK3" title="Dissolution expenses"&gt;50,000 &lt;/span&gt;of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders&#x2019; rights as shareholders (including the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#x2019;s remaining shareholders and its board of directors, dissolve and liquidate, subject in each case to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company&#x2019;s warrants, which will expire worthless if the Company fails to complete the Business Combination within the 18 months from the closing of this offering or during any Extension Period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Founder shares except as described below, are identical to the ordinary shares included in the units being sold in this offering, and holders of Founder shares have the same shareholder rights as public shareholders, except that (a) prior to the initial Business Combination, only holders of the founder shares have the right to vote on the appointment of directors and holders of a majority of the founder shares may remove a member of the board of directors for any reason; (b) in a vote to continue the company in a jurisdiction outside of the Cayman Islands, holders of founder shares will have ten votes for every founder share and holders of ordinary shares will have one vote for every ordinary share; (c) the Founder shares are subject to certain transfer restrictions, as described in more detail below; (d) the Company&#x2019;s initial shareholder has entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder shares in connection with the completion of the Company&#x2019;s initial Business Combination, (ii) waive their redemption rights with respect to their Founder shares and public shares in connection with a stockholder vote to approve an amendment to the Company&#x2019;s second amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company&#x2019;s obligation to provide for the redemption of the Company&#x2019;s public shares in connection with an initial Business Combination or to redeem 100% of the Company&#x2019;s public shares if the Company has not consummated an initial Business Combination within 18 months from the closing of this offering or during any Extension Period, and (B) with respect to any other provisions relating to shareholders&#x2019; rights, and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder shares if the Company fails to complete its initial Business Combination within 18 months from the closing of this offering or during any Extension Period, (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete its initial Business Combination within the prescribed time frame), and are entitled to registration rights. If the Company submits its initial Business Combination to its public shareholders for a vote, its founder has agreed (and its permitted transferees will agree) to vote their Founder shares, private placement shares and any public shares purchased during or after this offering in favor of its initial Business Combination. The other members of the Company&#x2019;s management team have entered into agreements similar to the one entered into by the Company&#x2019;s Sponsor with respect to any public shares acquired by them in or after this offering.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;





































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company will have until 18 months from the closing of the IPO (or up to 24 months from the closing of this offering if the Company extends the period of time to consummate a Business Combination by up to six additional months through six one-month extensions of time, as further provided in the Company&#x2019;s amended and restated memorandum and articles of association) to consummate a Business Combination (the &#x201c;Combination Period&#x201d;). On March 4, 2026, the Company effected the first of such six possible one-month extensions (the &#x201c;First Extension&#x201d;), extending the deadline to consummate a Business Combination from March 13, 2026 to April 13, 2026. On April 8, 2026, the Company effected the second of such six possible one-month extensions (the &#x201c;Second Extension&#x201d;), extending the deadline from April 13, 2026 to May 13, 2026. On May 8, 2026, the Company effected the third of such six possible one-month extensions (the &#x201c;Third Extension&#x201d;), extending the deadline from May 13, 2026 to June 13, 2026. On June 8, 2026, the Company effected the fourth of such six possible one-month extensions (the &#x201c;Fourth Extension&#x201d;), extending the deadline from June 13, 2026 to July 13, 2026. On July 8, 2026, the Company effected the fifth of such six possible one-month extensions (the &#x201c;Fifth Extension&#x201d;), extending the deadline from July 13, 2026 to August 13, 2026. The First, Second, Third, Fourth and Fifth Extensions are collectively referred to as the &#x201c;Extensions&#x201d;. In connection with each of the Extensions, the Sponsor deposited $&lt;span id="xdx_900_eus-gaap--Deposits_iI_c20260630_z79jzIEH5mc6" title="Deposits"&gt;191,475&lt;/span&gt; into the Trust Account as the Extension Fee, and the Company issued an unsecured, non-interest bearing promissory note to the Sponsor in the same principal amount (see Note 4). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company to pay its franchise and income taxes as well as expenses relating to the administration of the trust account (less up to $&lt;span id="xdx_90E_ecustom--DissolutionExpenses_c20260101__20260630_zLbcTO8gAZbk"&gt;50,000 &lt;/span&gt;of interest released to the Company to pay taxes and potentially, dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders&#x2019; rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and the Company&#x2019;s board of directors, dissolve and liquidate, subject in each case to our obligations under the Companies Act to provide for claims of creditors and the requirements of other applicable law.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.05).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than our independent registered public accounting firm) for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.05 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party or prospective target business who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company&#x2019;s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Company&#x2019;s Sponsor will not be responsible to the extent of any liability for such third party claims.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 28, 2024, the Company, VIWO Technology Inc., a Cayman Islands exempted company (&#x201c;VIWO&#x201d;) and the Merger Sub, have agreed to a Business Combination under the terms of a Merger Agreement (the &#x201c;VIWO Merger Agreement&#x201d;), pursuant to which the Merger Sub will merge with and into VIWO, with VIWO surviving the merger (the &#x201c;VIWO Merger&#x201d;). As a result, VIWO will be a wholly-owned subsidiary of Future Vision. The former security holders of VIWO will receive &lt;span id="xdx_90F_ecustom--FutureVisionOrdinaryShares_iI_c20241128_zN5ZmQ13tIjc" title="Future vision ordinary shares"&gt;9,950,250&lt;/span&gt; VIWO ordinary shares valued at $&lt;span id="xdx_900_ecustom--FutureVisionOrdinaryValue_iI_pn3n3_dm_c20241128_zI5yEVp9WDe6" title="Future vision ordinary value"&gt;100&lt;/span&gt; million equal to approximately 54.89% of the ordinary shares issued and outstanding of VIWO as consideration upon the consummation of the Business Combination (&#x201c;Consideration Shares&#x201d;).The VIWO Merger Agreement contains customary representations, warranties and covenants of the parties thereto. The consummation of the proposed VIWO Merger is subject to certain conditions as further described in the VIWO Merger Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;







































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company filed a Form 8-K with the SEC on November 29, 2024 to announce the VIWO Merger Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 10, 2024, the parties entered into Amendment No. 1 to the VIWO Merger Agreement requiring the Company to cause VIWO shareholders to enter into a lock up agreement with respect to the Consideration Shares to be received by the VIWO shareholders after the consummation of the Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company filed a Form 8-K with the SEC on December&#160;11, 2024 to announce Amendment No. 1 to the VIWO Merger Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 29, 2025, VIWO delivered a written notice to the Company and the Merger Sub, terminating that certain VIWO Merger Agreement, dated as of November 28, 2024 (as amended by Amendment No. 1 dated December 10, 2024), by and among VIWO, the Company and the Merger Sub. The termination was effected pursuant to Section 11.1(b) of the VIWO Merger Agreement, on the grounds that the merger had not been consummated on or prior to November 28, 2025 (the &lt;span style="font-family: DengXian"&gt;&#x201c;&lt;/span&gt;Outside Closing Date&lt;span style="font-family: DengXian"&gt;&#x201d;&lt;/span&gt;). Upon termination, the VIWO Merger Agreement became void and of no further effect, without any liability or obligation on the part of any party thereto.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company filed a Form 8-K with the SEC on December&#160;29, 2025 to announce termination of the VIWO Merger Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 16, 2026, the Company, the Merger Sub and MicroTouch Technology INC (&#x201c;MicroTouch&#x201d;), entered into a Merger Agreement (the &#x201c;MicroTouch Merger Agreement&#x201d;). Pursuant to the MicroTouch Merger Agreement, Merger Sub will merge with and into MicroTouch, with MicroTouch surviving the merger as a wholly owned subsidiary of the Company (the &#x201c;MicroTouch Merger&#x201d;). Upon effectiveness of the MicroTouch Merger, the Company will change its name to &#x201c;MicroTouch Inc.&#x201d; or another name determined by MicroTouch, subject to approval by the Registrar of Companies in the Cayman Islands.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company filed a Form 8-K with the SEC on January 20, 2026 to announce the MicroTouch Merger Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On May 11, 2026, the Company filed a Registration Statement on Form S-4 with the SEC in connection with the MicroTouch Merger. On June&#160;12, 2026, the Company filed Amendment No. 1 to the Form S-4. On June 26, 2026, the SEC declared the Form S-4 effective.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;On July&lt;/span&gt;&#160;&lt;span style="font-size: 10pt"&gt;23, 2026, the Company held an extraordinary general meeting (the &#x201c;EGM&#x201d;), at which its shareholders approved the MicroTouch Merger contemplated by the MicroTouch Merger Agreement. The Company filed a Form 8-K with the SEC on July&lt;/span&gt;&#160;&lt;span style="font-size: 10pt"&gt;27, 2026 to report the results of the EGM.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Going Concern Consideration&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June&#160;30, 2026, the Company had $&lt;span id="xdx_901_eus-gaap--Cash_iI_c20260630_zfZd83IRfFUf" title="Cash"&gt;788,401&lt;/span&gt; of cash in its operating bank account, and working capital deficit of $&lt;span id="xdx_90B_ecustom--WorkingCapitalDeficit_iI_pp0p0_c20260630_zdkM5RhqRoK9" title="Working capital deficit"&gt;151,600&lt;/span&gt;. In connection with the Company&#x2019;s assessment of going concern considerations in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 205-40 &#x201c;Going Concern,&#x201d; and through the consummation of the IPO on September 13, 2024, the Company has sufficient funds for the working capital needs of the Company until a minimum of one year from the date of issuance of these financial statements. However, the Company has until September&#160;13, 2026 to consummate the Initial Business Combination. If a business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the need to satisfy this mandatory liquidation, should a business combination not occur, and the potential subsequent dissolution, raises substantial doubt about the Company&lt;span style="font-family: DengXian"&gt;&#x2019;&lt;/span&gt;s ability to continue as a going concern.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company intends to complete the Initial Business Combination before the mandatory liquidation date. However, there can be no assurance that the Company will be able to consummate any business combination by September 13, 2026. No adjustments have been made to the carrying amounts and classification of assets or liabilities should the Company be required to liquidate after such date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;













































</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-09-012024-09-13_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000402"
      unitRef="Shares">5000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-09-13_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000403"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2024-09-012024-09-13_custom_OrdinarySharesMember"
      decimals="0"
      id="Fact000404"
      unitRef="USD">50000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2024-09-13"
      decimals="0"
      id="Fact000405"
      unitRef="USD">1845513</us-gaap:DeferredOfferingCosts>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2024-09-012024-09-13_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000406"
      unitRef="Shares">750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2024-09-012024-09-13_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000407"
      unitRef="USD">7500000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-09-012024-09-13_custom_RepresentativeSharesMember"
      decimals="INF"
      id="Fact000408"
      unitRef="Shares">57500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-09-13_custom_RepresentativeSharesMember"
      decimals="INF"
      id="Fact000409"
      unitRef="Shares">28750</us-gaap:SharesIssued>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-01-012026-06-30_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000410"
      unitRef="Shares">299000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-06-30_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000411"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2026-01-012026-06-30_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact000412"
      unitRef="USD">2990000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <FVNNU:BusinessCombinationPercentageOfVotingSecurities
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000414"
      unitRef="Pure">0.50</FVNNU:BusinessCombinationPercentageOfVotingSecurities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2024-09-012024-09-13_us-gaap_IPOMember"
      decimals="0"
      id="Fact000415"
      unitRef="USD">57500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-09-13_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000416"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <FVNNU:NetTangibleAssets
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000423"
      unitRef="USD">5000001</FVNNU:NetTangibleAssets>
    <FVNNU:DissolutionExpenses
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000425"
      unitRef="USD">50000</FVNNU:DissolutionExpenses>
    <us-gaap:Deposits
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000432"
      unitRef="USD">191475</us-gaap:Deposits>
    <FVNNU:DissolutionExpenses
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000433"
      unitRef="USD">50000</FVNNU:DissolutionExpenses>
    <FVNNU:FutureVisionOrdinaryShares
      contextRef="AsOf2024-11-28"
      decimals="INF"
      id="Fact000435"
      unitRef="Shares">9950250</FVNNU:FutureVisionOrdinaryShares>
    <FVNNU:FutureVisionOrdinaryValue
      contextRef="AsOf2024-11-28"
      decimals="-3"
      id="Fact000437"
      unitRef="USD">100000000</FVNNU:FutureVisionOrdinaryValue>
    <us-gaap:Cash
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000444"
      unitRef="USD">788401</us-gaap:Cash>
    <FVNNU:WorkingCapitalDeficit
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000446"
      unitRef="USD">151600</FVNNU:WorkingCapitalDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000453">&lt;p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zKT2QBEjOXr3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 2 &#x2014; &lt;span id="xdx_82A_z7d6EhmEEp07"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;





&lt;p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z6PqMHu9hop7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86F_zuJ7MBcEMan5"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and disclosures necessary for a complete presentation of financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments which are considered necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. The results of operations for the six months ended June&#160;30, 2026 are not necessarily indicative of the operating results for the full year ending December&#160;31, 2026 or any other future period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2025 as filed with the SEC on March&#160;6, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;








&lt;p id="xdx_846_ecustom--PrinciplesOfConsolidationPolicyTextBlock_zGarBHL1HSB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_863_zwDdtFVSwGGc"&gt;Principles of Consolidation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The unaudited condensed consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiary, Future Vision II Acquisition Merger Subsidiary Corp, a Cayman Islands exempted company which was formed in November&#160;12, 2024 for the purpose of consummating a Business Combination. All transactions and balances among the Company and its subsidiary have been eliminated upon consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;




&lt;p id="xdx_84C_ecustom--EmergingGrowthCompanyStatusPolicyTextBlock_zOazIMtqAejl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_zR2ukNGPIuXj"&gt;&lt;b&gt;Emerging Growth Company Status&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is an &#x201c;emerging growth company&#x201d; as defined in Section&#160;2(a) of the Securities Act of 1933, as amended, (the &#x201c;Securities Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;







































&lt;p id="xdx_84B_eus-gaap--UseOfEstimates_zkjBnc2G5Fh7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86B_zct0Dqjowsf8"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of incomes and expenses during the reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from these estimates. Significant estimates made by management on the condensed consolidated financial statements include, but are not limited to, the fair value of public rights and the redemption value of redeemable shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;









&lt;p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ze5Chi2FpDa9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86D_zkDgcIIUNlYc"&gt;&lt;b&gt;Cash&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash includes demand deposits with banks that the company may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;p id="xdx_84D_ecustom--InvestmentHeldInTrustAccountPolicyTextBlock_zYbXMsE6O6nb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_864_z7HE8DoChAqh"&gt;&lt;b&gt;Marketable Securities Held in Trust Account&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June&#160;30, 2026 and December&#160;31, 2025, all of the assets held in the Trust Account were held in U.S. Treasury Securities Money Market Funds. All of the Company&#x2019;s investments held in the Trust Account are classified as marketable securities. Marketable securities are presented on the condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in income earned on marketable securities held in Trust Account on the condensed consolidated statement of operations and comprehensive income. The estimated fair values of marketable securities held in Trust Account are determined using available market information. As of June&#160;30, 2026 and December&#160;31, 2025, the estimated fair value of marketable securities held in Trust Account was $&lt;span id="xdx_901_eus-gaap--MarketableSecurities_iI_c20260630_zBLjihtKBb55" title="Marketable securities"&gt;62,882,640 &lt;/span&gt;and $&lt;span id="xdx_90B_eus-gaap--MarketableSecurities_iI_c20251231_zi4A57GUmXF6" title="Marketable securities"&gt;61,035,590&lt;/span&gt;, respectively. For the three months ended June&#160;30, 2026 and 2025, the Company recorded income earned on investments held in Trust Account of $&lt;span id="xdx_908_eus-gaap--InterestIncomeExpenseNet_c20260401__20260630_zS3UzEpS56Tl" title="Investments held in trust account"&gt;545,639&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--InterestIncomeExpenseNet_c20250401__20250630_zZQyPy5k02l2" title="Investments held in trust account"&gt;614,436&lt;/span&gt;, respectively. For the six months ended June&#160;30, 2026 and 2025, the Company recorded income earned on investments held in Trust Account of $&lt;span id="xdx_90F_eus-gaap--InterestIncomeExpenseNet_c20260101__20260630_z7SEkqiqiDG5" title="Investments held in trust account"&gt;1,081,150&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--InterestIncomeExpenseNet_c20250101__20250630_zPDUlGXRhvya" title="Investments held in trust account"&gt;1,226,797&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June&#160;30, 2026, the Company classified its marketable securities held in the Trust Account as current assets, as the mandatory redemption date of September 13, 2026 is within one year from the date of condensed consolidated balance sheet.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_z9kuC21LcDTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_861_zzZg2iIJ9CUe"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in financial institution which, at times may exceed the Federal depository insurance coverage of $&lt;span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_c20260630_zFjIZATRoBu6" title="Federal depository insurance coverage"&gt;250,000&lt;/span&gt; and marketable securities held in Trust Account. Also, the Company maintains certain bank accounts in Hong Kong, where cash balances are protected under Deposit Protection Scheme in accordance with the Deposit Protection Scheme Ordinance, with the maximum protection of up to HKD500,000 per depositor per Scheme member, including both principal and interest. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;p id="xdx_847_ecustom--OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock_z6MXenV4sjHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_zwUQyMmVg40a"&gt;&lt;b&gt;Offering Costs Associated with the Initial Public Offering&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the IPO that were directly related to the IPO. Offering cost amounted to $&lt;span id="xdx_90A_ecustom--OfferingCosts_c20260101__20260630_zlmWCFiFffj" title="Offering costs"&gt;1,845,513&lt;/span&gt;, consisting of $&lt;span id="xdx_902_ecustom--Consisting_c20260101__20260630_zvSppKl3CeJl" title="Consisting"&gt;862,500 &lt;/span&gt;and $&lt;span id="xdx_901_ecustom--UnderwritingCommissions_c20260101__20260630_zISerh1k9OLl" title="Underwriting commissions"&gt;522,019 &lt;/span&gt;of underwriting commissions which were paid in cash and representative shares (57,500 ordinary shares) at the closing date of the IPO, respectively and $&lt;span id="xdx_903_ecustom--OtherOfferingCosts_c20260101__20260630_zEri9RKx5dOi" title="Other offering costs"&gt;460,994 &lt;/span&gt;of other offering costs. The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic 5A - &#x201c;Expenses of Offering&#x201d;. The Company allocates offering costs among public shares, public rights based on the relative fair values of public shares and public rights.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















































&lt;p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFcLE6QFk0K6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_867_zUTlG3F5aGnf"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC Topic 820 &#x201c;Fair Value Measurements&#x201d; defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC Topic 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company&#x2019;s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The fair value hierarchy is categorized into three levels based on the inputs as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 2 - Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820 approximates the carrying amounts represented on the accompanying condensed consolidated balance sheet, primarily due to their short-term nature. The carrying amounts reported on the condensed consolidated balance sheets for cash, due to a related party and promissory note &#x2013; a related party, each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period between the origination of such instruments and their expected realization and their current market rate of interest.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table presents information about the Company&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2019;&lt;/span&gt;s assets that are measured at fair value on a recurring basis as of the presented periods, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zVr7qwl4ObIf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left"&gt;&lt;span id="xdx_8B1_z0e39b8vnRWk" style="display: none"&gt;Schedule of fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"&gt;Description&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt; 2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Assets:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; color: black; text-align: left"&gt;Marketable securities held in Trust Account&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10%; color: black; text-align: center"&gt;1&lt;/td&gt;
    &lt;td style="width: 2%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--MarketableSecurities_iI_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zBNTWzthlCEb" style="text-align: right; width: 9%; vertical-align: bottom" title="Marketable securities held in Trust Account"&gt;62,882,640&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--MarketableSecurities_iI_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_znEl8jpe0f0l" style="width: 9%; color: black; text-align: right" title="Marketable securities held in Trust Account"&gt;61,035,590&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;







&lt;p id="xdx_8AD_zxkzmKOtkxR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;









&lt;p id="xdx_846_ecustom--OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock_z9Xn2KVL1clj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_zOKfBRhPTFFi"&gt;&lt;b&gt;Ordinary Shares Subject to Possible Redemption&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All of the &lt;span id="xdx_90A_ecustom--OrdinarySharesSubjectToPossibleRedemption_iI_c20260630_zWTvML6KkFIi" title="Ordinary shares subject to possible redemption"&gt;5,750,000 &lt;/span&gt;Ordinary Shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company&#x2019;s amended and restated certificate of incorporation as disclosed in Note 1.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;





































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounted for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, &#x201c;Distinguishing Liabilities from Equity&#x201d; (ASC 480). Ordinary shares subject to mandatory redemption (if any) were classified as a liability instrument and will be measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) were classified as temporary equity. At all other times, ordinary shares were classified as stockholders&#x2019; equity. In accordance with ASC 480-10-S99, the Company classified the ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Given that the &lt;span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember_zauGc6VwHpy7" title="Number of shares sold"&gt;5,750,000&lt;/span&gt; ordinary shares sold as part of the units in the IPO were issued with other freestanding instruments (i.e., Rights), the initial carrying value of ordinary shares, net of allocated offering cost, has been classified as temporary equity, and has been allocated to the proceeds determined in accordance with ASC 470-20. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected the accretion method (i) to recognize the changes in redemption value as a charge against retained earnings or, in the absence of retained earnings, as a charge against additional paid-in capital, or in the absence of both retained earnings and additional paid-in capital, as an increase to accumulated deficit, over an expected 18-month period (which ended March 13, 2026), which is the initial period that the Company has to complete a Business Combination. Subsequent to the IPO date, the accretion also includes the dividend and interest income earned in the Trust Account in excess of franchise and income taxes as well as expenses relating to the administration of the trust account, if any, as well as required deposits to extend the deadline to complete a Business Combination ever since March 13, 2026. During the Extension Period subsequent to March 13, 2026, the Company changed the method to (ii) to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the three months ended June 30, 2026 and 2025, the Company recorded accretion of ordinary share subject to redemption value of $&lt;span id="xdx_90B_ecustom--AccretionsOfOrdinarySharesSubjectToRedemptionValue_c20260401__20260630_z9NQ0vtwsZBk" title="Accretion of ordinary share subject to redemption value"&gt;1,120,064&lt;/span&gt; and $&lt;span id="xdx_90A_ecustom--AccretionsOfOrdinarySharesSubjectToRedemptionValue_c20250401__20250630_zKFfMNtdl2Se" title="Accretion of ordinary share subject to redemption value"&gt;3,308,723&lt;/span&gt;, respectively. For the six months ended June 30, 2026 and 2025, the Company recorded accretion of ordinary share subject to redemption value of $&lt;span id="xdx_90C_ecustom--AccretionsOfOrdinarySharesSubjectToRedemptionValue_c20260101__20260630_zpsOM5goPbQi" title="Accretion of ordinary share subject to redemption value"&gt;2,784,862&lt;/span&gt; and $&lt;span id="xdx_90F_ecustom--AccretionsOfOrdinarySharesSubjectToRedemptionValue_c20250101__20250630_zx5DK1hFNLbe" title="Accretion of ordinary share subject to redemption value"&gt;4,409,321&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Ordinary shares subject to possible redemption reflected on the condensed consolidated balance sheets are recorded in the following table:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionTableTextBlock_zzhnyIpxGold" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"&gt;&lt;span id="xdx_8B0_zd8RI30VbW01" style="display: none"&gt;Schedule of Ordinary shares subject to possible redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Gross proceeds&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250101__20251231_z5OAStPzjk84" style="text-align: right" title="Gross proceeds"&gt;57,500,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;b&gt;Less:&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right" title="Gross proceeds"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Proceeds allocated to public rights&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ProceedsFromIssuanceOfWarrants_iN_di_c20250101__20251231_zfksKwFWVz2e" style="text-align: right" title="Proceeds allocated to public rights"&gt;(5,010,612&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Offering costs allocated to redeemable shares&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OfferingCostsAllocatedToRedeemableShares_c20250101__20251231_zpx23CBSbRMi" style="text-align: right" title="Offering costs allocated to redeemable shares"&gt;(1,684,693&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;b&gt;Plus:&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right" title="Gross proceeds"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Accretion of carrying value to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--AccretionExpense_c20250101__20251231_zhQhTj4EDG9i" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;9,293,083&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"&gt;&lt;b&gt;Ordinary shares subject to possible redemption as of December 31, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20260101__20260630_zwkQzO0hiTb3" style="border-bottom: Black 2.5pt double; width: 9%; text-align: right" title="Gross proceeds"&gt;&lt;b&gt;60,097,778&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: normal; text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: normal; vertical-align: top"&gt;&lt;span style="font-style: normal"&gt;&lt;b&gt;Plus:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt; vertical-align: top"&gt;Accretion of carrying value to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--AccretionExpense_c20260101__20260630_zDsagVH0h85g" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;2,784,862&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt; vertical-align: top"&gt;Ordinary shares subject to possible redemption as of June&#160;30, 2026 (Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OrdinarySharesSubjectToPossibleRedemptions_c20260101__20260630_zz1lV8XGkNg1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemptions"&gt;62,882,640&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;







&lt;p id="xdx_8A0_zdazZUdrwg28" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;







&lt;p id="xdx_843_ecustom--RelatedPartiesPolicyTextBlock_zQpzl30OjQUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_861_z37xHPw1pzTj"&gt;&lt;b&gt;Related Parties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or common significant influence.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;








































&lt;p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zdmOuKOflEJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_865_zMySQsY0HOi5"&gt;&lt;b&gt;Earnings (Loss) Per Ordinary Share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share&#x201d;. The unaudited condensed consolidated statements of operations and comprehensive income include a presentation of earnings (loss) per redeemable share and earnings (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the shares subject to possible redemption was considered to be dividends paid to the public shareholders. For the three and six months ended June&#160;30, 2026 and 2025, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Net income used in the calculation of earnings (loss) per share is as the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfConsolidatedStatementsOfOperationsTableTextBlock_zAWodC2PukBb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B1_zv82iv4mg3Cc" style="display: none"&gt;Schedule of consolidated statements of operations&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20260401__20260630_zpqIoBROM9rg" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20250401__20250630_zoLIfJyYEOGi" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260101__20260630_z1KZGTKctmy5" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250101__20250630_zXfKzgPWrEFa" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Three Months Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;For the&lt;br/&gt; Six Months Ended &lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; padding-left: 0.125in; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; padding-left: 0.125in; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--NetIncomeLoss_zHWY2iQnVkDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;Net income&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;409,985&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;551,900&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;828,741&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;1,006,200&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AccretionOfRedeemableOrdinarySharesSubjectToRedemptionValue_zf2BOSRhKPxd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Less: Accretion of redeemable ordinary shares to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,120,064&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,308,723&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,784,862&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,409,321&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NetLossIncludingAccretionOfRedemmableOrdinarySharesToRedemptionValue_z7gJqU8sObye" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;b&gt;Net loss including accretion of redeemable ordinary shares to redemption value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;(710,079&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;(2,756,823&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;(1,956,121&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;(3,403,121&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;





&lt;p id="xdx_8A9_zuKyoin2RTtg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Earnings (loss) per share presented on the unaudited condensed consolidated statement of operations and comprehensive income for the three months ended June&#160;30, 2026 and 2025 is based on the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z37F6bPGBeVg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BB_zz7rOeyRAMcd" style="display: none"&gt;Schedule of Basic and Diluted Net Loss Per Share&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260401__20260630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryShareMember_zNc7GQrVf599" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20260401__20260630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_z4Ix50J1zhZ6" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250401__20250630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryShareMember_zEUEtvrCFl5c" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20250401__20250630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zDAWh6oNKaWd" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended June&#160;30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--NumeratorsAbstract_iB_zuIcm3G7MIc6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"&gt;Numerators:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--AllocationOfNetLoss_zequ3sdgLAue" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;Allocation of net loss&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(541,219&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(168,860&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(2,101,237&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(655,586&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AccretionOfRedeemableOrdinarySharesToRedemptionValue_zRLisn7hvlqc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Accretion of redeemable ordinary shares to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,120,064&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0585"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,308,723&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0587"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AllocationOfNetincomeLoss_zjZs0DJ9A6D7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Allocation of net&#160;income (loss)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;578,845&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(168,860&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,207,486&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(655,586&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DenominatorAbstract_iB_zJWkdDmWYKxe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"&gt;Denominators:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Weighted-average ordinary shares outstanding&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zlCkueK2yLKi" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_ziWvvWGXMRyd" title="Diluted weighted average ordinary shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zrXMvSwP5rJ4" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zco4lHALhtb8" title="Diluted weighted average ordinary shares outstanding"&gt;1,794,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zxrGurgJ3LGk" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_z2kvWMttB2yl" title="Diluted weighted average ordinary shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zr7LLoq2Bs5j" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zHFWPzw7qfig" title="Diluted weighted average ordinary shares outstanding"&gt;1,794,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted earnings (loss) per share&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zaBaqkf9GQY8" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zj50DY3gK7Bh" title="Diluted earnings per ordinary share"&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareBasic_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zzkk7RJ5ac53" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zSWT1B6NSKgk" title="Diluted earnings per ordinary share"&gt;(0.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zttmA7A02VR9" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_z0qT7r51Nwh5" title="Diluted earnings per ordinary share"&gt;0.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_ze4hJzd6E5i6" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zTtBHGu4WYZ8" title="Diluted earnings per ordinary share"&gt;(0.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;







































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Earnings (loss) per share presented on the unaudited condensed consolidated statement of operations and comprehensive income for the six months ended June&#160;30, 2026 and 2025 is based on the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryShareMember_zeLrTmiWxGD9" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_z04vH5KKKDy4" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20250630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryShareMember_zMAuFs6XfBw9" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20250101__20250630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zQeRe8tjluFe" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the Six Months Ended June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;br/&gt;Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Redeemable&lt;br/&gt;Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;br/&gt;Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--NumeratorsAbstract_iB_zTOPMZS3BR3d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; font-weight: bold"&gt;Numerators:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--AllocationOfNetLoss_z3JtgCjb5kwl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 52%; color: black; text-align: left"&gt;Allocation of net loss&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; color: black; text-align: right"&gt;(1,490,946&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; color: black; text-align: right"&gt;(465,175&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; color: black; text-align: right"&gt;(2,593,842&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; color: black; text-align: right"&gt;(809,279&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AccretionOfRedeemableOrdinarySharesToRedemptionValue_zxSxk9pocuDe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left; padding-bottom: 1pt"&gt;Accretion of redeemable ordinary shares to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,784,862&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0647"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;4,409,321&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0649"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AllocationOfNetincomeLoss_zJ8EWvetwyhf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left; padding-bottom: 2.5pt"&gt;Allocation of net&#160;income (loss)&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;1,293,916&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;(465,175&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;1,815,479&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;(809,279&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DenominatorAbstract_iB_zIaPfMDknIng" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; font-weight: bold"&gt;Denominators:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left; padding-bottom: 2.5pt"&gt;Weighted-average ordinary shares outstanding&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zEfXrAHZ0fTj" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zaP8kfy69wIb" title="Diluted weighted average ordinary shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zJAkp18bFnwg" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_znJzMIT8LBe2" title="Diluted weighted average ordinary shares outstanding"&gt;1,794,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zpROthjtVSkl" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_z0IZhIDdbT9e" title="Diluted weighted average ordinary shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zXPqzxoSePr3" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zNdsxVKDlcTg" title="Diluted weighted average ordinary shares outstanding"&gt;1,794,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted earnings (loss) per share&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zgKEqTNy6qej" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareDiluted_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zjc2dZpfG999" title="Diluted earnings per ordinary share"&gt;0.23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zvGiOSk5nZjj" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zsxAjqQA2Xk2" title="Diluted earnings per ordinary share"&gt;(0.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareBasic_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zzyKrmErY14i" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zUVrm9JtRsd9" title="Diluted earnings per ordinary share"&gt;0.32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_z53F8GZzBOl4" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zqgJQb0tEID6" title="Diluted earnings per ordinary share"&gt;(0.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zqdHtAuYucP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;








&lt;p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zqlTlJfrPmKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86B_z1Xo2tEl8jJj"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for income taxes under ASC 740 Income Taxes (&#x201c;ASC 740&#x201d;). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were &lt;span id="xdx_905_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20260630_zmuA6o1LZ9uc"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20260630_z26xEHHe5AQ8"&gt;no&lt;/span&gt; amounts accrued for interest and penalties as of June&#160;30, 2026 and December&#160;31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company determined that the Cayman Islands is the Company&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2019;&lt;/span&gt;s only major tax jurisdiction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company may be subject to potential examination by taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2019;&lt;/span&gt;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There is currently no taxation imposed on income by the Government of the Cayman Islands for the three and six months ended June&#160;30, 2026 and 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





































&lt;p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z8T7TTsw6I93" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_864_zhckjOtjxLil"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2024, the FASB issued ASU 2024-03, Income Statement &lt;span style="font-family: DengXian"&gt;&#x2014;&lt;/span&gt; Reporting Comprehensive Income &lt;span style="font-family: DengXian"&gt;&#x2014;&lt;/span&gt; Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&lt;span style="font-family: DengXian"&gt;&#x201c;&lt;/span&gt;ASU 2024-03&lt;span style="font-family: DengXian"&gt;&#x201d;&lt;/span&gt;) which requires detailed disclosures in the notes to financial statements disaggregating specific expense categories and certain other disclosures to provide enhanced transparency into the nature and function of expenses. The FASB further clarified the effective date in January 2025 with the issuance of ASU 2025-01, Income Statement &lt;span style="font-family: DengXian"&gt;&#x2014;&lt;/span&gt; Reporting Comprehensive Income &lt;span style="font-family: DengXian"&gt;&#x2014;&lt;/span&gt; Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date (&lt;span style="font-family: DengXian"&gt;&#x201c;&lt;/span&gt;ASU 2025-01&lt;span style="font-family: DengXian"&gt;&#x201d;&lt;/span&gt;). ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The requirements should be applied on a prospective basis while retrospective application is permitted. The Company does not expect to adopt this guidance early and does not expect the adoption of this ASU to have a material impact on its condensed consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 8, 2025, the FASB issued ASU 2025-11 &lt;span style="font-family: DengXian"&gt;&#x2014;&lt;/span&gt; Interim Reporting (&lt;span style="font-family: DengXian"&gt;&#x201c;&lt;/span&gt;ASU 2025-11&lt;span style="font-family: DengXian"&gt;&#x201d;&lt;/span&gt;) which is intended to improve the navigability of the guidance in ASC 270, Interim Reporting, and clarify when it applies. Under the amendments, an entity is subject to ASC 270 if it provides interim financial statements and notes in accordance with GAAP. ASU 2025-11 also addresses the form and content of such financial statements, interim disclosures requirements, and establishes a principle under which an entity must disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, and early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2025-11 may have on its condensed consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management does not believe that any recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2019;&lt;/span&gt;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;





</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000455">&lt;p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z6PqMHu9hop7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86F_zuJ7MBcEMan5"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and disclosures necessary for a complete presentation of financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments which are considered necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. The results of operations for the six months ended June&#160;30, 2026 are not necessarily indicative of the operating results for the full year ending December&#160;31, 2026 or any other future period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2025 as filed with the SEC on March&#160;6, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;








</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <FVNNU:PrinciplesOfConsolidationPolicyTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000457">&lt;p id="xdx_846_ecustom--PrinciplesOfConsolidationPolicyTextBlock_zGarBHL1HSB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_863_zwDdtFVSwGGc"&gt;Principles of Consolidation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The unaudited condensed consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiary, Future Vision II Acquisition Merger Subsidiary Corp, a Cayman Islands exempted company which was formed in November&#160;12, 2024 for the purpose of consummating a Business Combination. All transactions and balances among the Company and its subsidiary have been eliminated upon consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;




</FVNNU:PrinciplesOfConsolidationPolicyTextBlock>
    <FVNNU:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000459">&lt;p id="xdx_84C_ecustom--EmergingGrowthCompanyStatusPolicyTextBlock_zOazIMtqAejl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_zR2ukNGPIuXj"&gt;&lt;b&gt;Emerging Growth Company Status&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is an &#x201c;emerging growth company&#x201d; as defined in Section&#160;2(a) of the Securities Act of 1933, as amended, (the &#x201c;Securities Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;







































</FVNNU:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2026-01-01to2026-06-30" id="Fact000466">&lt;p id="xdx_84B_eus-gaap--UseOfEstimates_zkjBnc2G5Fh7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86B_zct0Dqjowsf8"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of incomes and expenses during the reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from these estimates. Significant estimates made by management on the condensed consolidated financial statements include, but are not limited to, the fair value of public rights and the redemption value of redeemable shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;









</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000468">&lt;p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ze5Chi2FpDa9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86D_zkDgcIIUNlYc"&gt;&lt;b&gt;Cash&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash includes demand deposits with banks that the company may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <FVNNU:InvestmentHeldInTrustAccountPolicyTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000470">&lt;p id="xdx_84D_ecustom--InvestmentHeldInTrustAccountPolicyTextBlock_zYbXMsE6O6nb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_864_z7HE8DoChAqh"&gt;&lt;b&gt;Marketable Securities Held in Trust Account&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June&#160;30, 2026 and December&#160;31, 2025, all of the assets held in the Trust Account were held in U.S. Treasury Securities Money Market Funds. All of the Company&#x2019;s investments held in the Trust Account are classified as marketable securities. Marketable securities are presented on the condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in income earned on marketable securities held in Trust Account on the condensed consolidated statement of operations and comprehensive income. The estimated fair values of marketable securities held in Trust Account are determined using available market information. As of June&#160;30, 2026 and December&#160;31, 2025, the estimated fair value of marketable securities held in Trust Account was $&lt;span id="xdx_901_eus-gaap--MarketableSecurities_iI_c20260630_zBLjihtKBb55" title="Marketable securities"&gt;62,882,640 &lt;/span&gt;and $&lt;span id="xdx_90B_eus-gaap--MarketableSecurities_iI_c20251231_zi4A57GUmXF6" title="Marketable securities"&gt;61,035,590&lt;/span&gt;, respectively. For the three months ended June&#160;30, 2026 and 2025, the Company recorded income earned on investments held in Trust Account of $&lt;span id="xdx_908_eus-gaap--InterestIncomeExpenseNet_c20260401__20260630_zS3UzEpS56Tl" title="Investments held in trust account"&gt;545,639&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--InterestIncomeExpenseNet_c20250401__20250630_zZQyPy5k02l2" title="Investments held in trust account"&gt;614,436&lt;/span&gt;, respectively. For the six months ended June&#160;30, 2026 and 2025, the Company recorded income earned on investments held in Trust Account of $&lt;span id="xdx_90F_eus-gaap--InterestIncomeExpenseNet_c20260101__20260630_z7SEkqiqiDG5" title="Investments held in trust account"&gt;1,081,150&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--InterestIncomeExpenseNet_c20250101__20250630_zPDUlGXRhvya" title="Investments held in trust account"&gt;1,226,797&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June&#160;30, 2026, the Company classified its marketable securities held in the Trust Account as current assets, as the mandatory redemption date of September 13, 2026 is within one year from the date of condensed consolidated balance sheet.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





</FVNNU:InvestmentHeldInTrustAccountPolicyTextBlock>
    <us-gaap:MarketableSecurities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000472"
      unitRef="USD">62882640</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000474"
      unitRef="USD">61035590</us-gaap:MarketableSecurities>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000476"
      unitRef="USD">545639</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000478"
      unitRef="USD">614436</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000480"
      unitRef="USD">1081150</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000482"
      unitRef="USD">1226797</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2026-01-01to2026-06-30" id="Fact000484">&lt;p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_z9kuC21LcDTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_861_zzZg2iIJ9CUe"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in financial institution which, at times may exceed the Federal depository insurance coverage of $&lt;span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_c20260630_zFjIZATRoBu6" title="Federal depository insurance coverage"&gt;250,000&lt;/span&gt; and marketable securities held in Trust Account. Also, the Company maintains certain bank accounts in Hong Kong, where cash balances are protected under Deposit Protection Scheme in accordance with the Deposit Protection Scheme Ordinance, with the maximum protection of up to HKD500,000 per depositor per Scheme member, including both principal and interest. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;





</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000486"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <FVNNU:OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000488">&lt;p id="xdx_847_ecustom--OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock_z6MXenV4sjHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_zwUQyMmVg40a"&gt;&lt;b&gt;Offering Costs Associated with the Initial Public Offering&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the IPO that were directly related to the IPO. Offering cost amounted to $&lt;span id="xdx_90A_ecustom--OfferingCosts_c20260101__20260630_zlmWCFiFffj" title="Offering costs"&gt;1,845,513&lt;/span&gt;, consisting of $&lt;span id="xdx_902_ecustom--Consisting_c20260101__20260630_zvSppKl3CeJl" title="Consisting"&gt;862,500 &lt;/span&gt;and $&lt;span id="xdx_901_ecustom--UnderwritingCommissions_c20260101__20260630_zISerh1k9OLl" title="Underwriting commissions"&gt;522,019 &lt;/span&gt;of underwriting commissions which were paid in cash and representative shares (57,500 ordinary shares) at the closing date of the IPO, respectively and $&lt;span id="xdx_903_ecustom--OtherOfferingCosts_c20260101__20260630_zEri9RKx5dOi" title="Other offering costs"&gt;460,994 &lt;/span&gt;of other offering costs. The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic 5A - &#x201c;Expenses of Offering&#x201d;. The Company allocates offering costs among public shares, public rights based on the relative fair values of public shares and public rights.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















































</FVNNU:OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock>
    <FVNNU:OfferingCosts
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000490"
      unitRef="USD">1845513</FVNNU:OfferingCosts>
    <FVNNU:Consisting
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000492"
      unitRef="USD">862500</FVNNU:Consisting>
    <FVNNU:UnderwritingCommissions
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000494"
      unitRef="USD">522019</FVNNU:UnderwritingCommissions>
    <FVNNU:OtherOfferingCosts
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000496"
      unitRef="USD">460994</FVNNU:OtherOfferingCosts>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2026-01-01to2026-06-30" id="Fact000503">&lt;p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFcLE6QFk0K6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_867_zUTlG3F5aGnf"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC Topic 820 &#x201c;Fair Value Measurements&#x201d; defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC Topic 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company&#x2019;s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The fair value hierarchy is categorized into three levels based on the inputs as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 2 - Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820 approximates the carrying amounts represented on the accompanying condensed consolidated balance sheet, primarily due to their short-term nature. The carrying amounts reported on the condensed consolidated balance sheets for cash, due to a related party and promissory note &#x2013; a related party, each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period between the origination of such instruments and their expected realization and their current market rate of interest.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table presents information about the Company&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2019;&lt;/span&gt;s assets that are measured at fair value on a recurring basis as of the presented periods, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zVr7qwl4ObIf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left"&gt;&lt;span id="xdx_8B1_z0e39b8vnRWk" style="display: none"&gt;Schedule of fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"&gt;Description&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt; 2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Assets:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; color: black; text-align: left"&gt;Marketable securities held in Trust Account&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10%; color: black; text-align: center"&gt;1&lt;/td&gt;
    &lt;td style="width: 2%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--MarketableSecurities_iI_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zBNTWzthlCEb" style="text-align: right; width: 9%; vertical-align: bottom" title="Marketable securities held in Trust Account"&gt;62,882,640&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--MarketableSecurities_iI_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_znEl8jpe0f0l" style="width: 9%; color: black; text-align: right" title="Marketable securities held in Trust Account"&gt;61,035,590&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;







&lt;p id="xdx_8AD_zxkzmKOtkxR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;









</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000505">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zVr7qwl4ObIf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left"&gt;&lt;span id="xdx_8B1_z0e39b8vnRWk" style="display: none"&gt;Schedule of fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"&gt;Description&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;b&gt;June&#160;30,&lt;br/&gt; 2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Assets:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; color: black; text-align: left"&gt;Marketable securities held in Trust Account&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10%; color: black; text-align: center"&gt;1&lt;/td&gt;
    &lt;td style="width: 2%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--MarketableSecurities_iI_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zBNTWzthlCEb" style="text-align: right; width: 9%; vertical-align: bottom" title="Marketable securities held in Trust Account"&gt;62,882,640&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--MarketableSecurities_iI_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_znEl8jpe0f0l" style="width: 9%; color: black; text-align: right" title="Marketable securities held in Trust Account"&gt;61,035,590&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;







</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:MarketableSecurities
      contextRef="AsOf2026-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact000507"
      unitRef="USD">62882640</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="AsOf2025-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact000509"
      unitRef="USD">61035590</us-gaap:MarketableSecurities>
    <FVNNU:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000511">&lt;p id="xdx_846_ecustom--OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock_z9Xn2KVL1clj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86A_zOKfBRhPTFFi"&gt;&lt;b&gt;Ordinary Shares Subject to Possible Redemption&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All of the &lt;span id="xdx_90A_ecustom--OrdinarySharesSubjectToPossibleRedemption_iI_c20260630_zWTvML6KkFIi" title="Ordinary shares subject to possible redemption"&gt;5,750,000 &lt;/span&gt;Ordinary Shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company&#x2019;s amended and restated certificate of incorporation as disclosed in Note 1.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;





































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounted for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, &#x201c;Distinguishing Liabilities from Equity&#x201d; (ASC 480). Ordinary shares subject to mandatory redemption (if any) were classified as a liability instrument and will be measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) were classified as temporary equity. At all other times, ordinary shares were classified as stockholders&#x2019; equity. In accordance with ASC 480-10-S99, the Company classified the ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Given that the &lt;span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember_zauGc6VwHpy7" title="Number of shares sold"&gt;5,750,000&lt;/span&gt; ordinary shares sold as part of the units in the IPO were issued with other freestanding instruments (i.e., Rights), the initial carrying value of ordinary shares, net of allocated offering cost, has been classified as temporary equity, and has been allocated to the proceeds determined in accordance with ASC 470-20. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected the accretion method (i) to recognize the changes in redemption value as a charge against retained earnings or, in the absence of retained earnings, as a charge against additional paid-in capital, or in the absence of both retained earnings and additional paid-in capital, as an increase to accumulated deficit, over an expected 18-month period (which ended March 13, 2026), which is the initial period that the Company has to complete a Business Combination. Subsequent to the IPO date, the accretion also includes the dividend and interest income earned in the Trust Account in excess of franchise and income taxes as well as expenses relating to the administration of the trust account, if any, as well as required deposits to extend the deadline to complete a Business Combination ever since March 13, 2026. During the Extension Period subsequent to March 13, 2026, the Company changed the method to (ii) to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the three months ended June 30, 2026 and 2025, the Company recorded accretion of ordinary share subject to redemption value of $&lt;span id="xdx_90B_ecustom--AccretionsOfOrdinarySharesSubjectToRedemptionValue_c20260401__20260630_z9NQ0vtwsZBk" title="Accretion of ordinary share subject to redemption value"&gt;1,120,064&lt;/span&gt; and $&lt;span id="xdx_90A_ecustom--AccretionsOfOrdinarySharesSubjectToRedemptionValue_c20250401__20250630_zKFfMNtdl2Se" title="Accretion of ordinary share subject to redemption value"&gt;3,308,723&lt;/span&gt;, respectively. For the six months ended June 30, 2026 and 2025, the Company recorded accretion of ordinary share subject to redemption value of $&lt;span id="xdx_90C_ecustom--AccretionsOfOrdinarySharesSubjectToRedemptionValue_c20260101__20260630_zpsOM5goPbQi" title="Accretion of ordinary share subject to redemption value"&gt;2,784,862&lt;/span&gt; and $&lt;span id="xdx_90F_ecustom--AccretionsOfOrdinarySharesSubjectToRedemptionValue_c20250101__20250630_zx5DK1hFNLbe" title="Accretion of ordinary share subject to redemption value"&gt;4,409,321&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Ordinary shares subject to possible redemption reflected on the condensed consolidated balance sheets are recorded in the following table:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionTableTextBlock_zzhnyIpxGold" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"&gt;&lt;span id="xdx_8B0_zd8RI30VbW01" style="display: none"&gt;Schedule of Ordinary shares subject to possible redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Gross proceeds&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250101__20251231_z5OAStPzjk84" style="text-align: right" title="Gross proceeds"&gt;57,500,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;b&gt;Less:&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right" title="Gross proceeds"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Proceeds allocated to public rights&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ProceedsFromIssuanceOfWarrants_iN_di_c20250101__20251231_zfksKwFWVz2e" style="text-align: right" title="Proceeds allocated to public rights"&gt;(5,010,612&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Offering costs allocated to redeemable shares&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OfferingCostsAllocatedToRedeemableShares_c20250101__20251231_zpx23CBSbRMi" style="text-align: right" title="Offering costs allocated to redeemable shares"&gt;(1,684,693&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;b&gt;Plus:&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right" title="Gross proceeds"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Accretion of carrying value to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--AccretionExpense_c20250101__20251231_zhQhTj4EDG9i" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;9,293,083&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"&gt;&lt;b&gt;Ordinary shares subject to possible redemption as of December 31, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20260101__20260630_zwkQzO0hiTb3" style="border-bottom: Black 2.5pt double; width: 9%; text-align: right" title="Gross proceeds"&gt;&lt;b&gt;60,097,778&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: normal; text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: normal; vertical-align: top"&gt;&lt;span style="font-style: normal"&gt;&lt;b&gt;Plus:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt; vertical-align: top"&gt;Accretion of carrying value to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--AccretionExpense_c20260101__20260630_zDsagVH0h85g" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;2,784,862&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt; vertical-align: top"&gt;Ordinary shares subject to possible redemption as of June&#160;30, 2026 (Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OrdinarySharesSubjectToPossibleRedemptions_c20260101__20260630_zz1lV8XGkNg1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemptions"&gt;62,882,640&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;







&lt;p id="xdx_8A0_zdazZUdrwg28" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;







</FVNNU:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock>
    <FVNNU:OrdinarySharesSubjectToPossibleRedemption
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000513"
      unitRef="Shares">5750000</FVNNU:OrdinarySharesSubjectToPossibleRedemption>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-01-012026-06-30_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000520"
      unitRef="Shares">5750000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <FVNNU:AccretionsOfOrdinarySharesSubjectToRedemptionValue
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000522"
      unitRef="USD">1120064</FVNNU:AccretionsOfOrdinarySharesSubjectToRedemptionValue>
    <FVNNU:AccretionsOfOrdinarySharesSubjectToRedemptionValue
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000524"
      unitRef="USD">3308723</FVNNU:AccretionsOfOrdinarySharesSubjectToRedemptionValue>
    <FVNNU:AccretionsOfOrdinarySharesSubjectToRedemptionValue
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000526"
      unitRef="USD">2784862</FVNNU:AccretionsOfOrdinarySharesSubjectToRedemptionValue>
    <FVNNU:AccretionsOfOrdinarySharesSubjectToRedemptionValue
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000528"
      unitRef="USD">4409321</FVNNU:AccretionsOfOrdinarySharesSubjectToRedemptionValue>
    <FVNNU:ScheduleOfOrdinarySharesSubjectToPossibleRedemptionTableTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000530">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfOrdinarySharesSubjectToPossibleRedemptionTableTextBlock_zzhnyIpxGold" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"&gt;&lt;span id="xdx_8B0_zd8RI30VbW01" style="display: none"&gt;Schedule of Ordinary shares subject to possible redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Gross proceeds&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250101__20251231_z5OAStPzjk84" style="text-align: right" title="Gross proceeds"&gt;57,500,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;b&gt;Less:&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right" title="Gross proceeds"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Proceeds allocated to public rights&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ProceedsFromIssuanceOfWarrants_iN_di_c20250101__20251231_zfksKwFWVz2e" style="text-align: right" title="Proceeds allocated to public rights"&gt;(5,010,612&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Offering costs allocated to redeemable shares&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OfferingCostsAllocatedToRedeemableShares_c20250101__20251231_zpx23CBSbRMi" style="text-align: right" title="Offering costs allocated to redeemable shares"&gt;(1,684,693&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;b&gt;Plus:&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right" title="Gross proceeds"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Accretion of carrying value to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--AccretionExpense_c20250101__20251231_zhQhTj4EDG9i" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;9,293,083&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"&gt;&lt;b&gt;Ordinary shares subject to possible redemption as of December 31, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; width: 1%"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20260101__20260630_zwkQzO0hiTb3" style="border-bottom: Black 2.5pt double; width: 9%; text-align: right" title="Gross proceeds"&gt;&lt;b&gt;60,097,778&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: normal; text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: normal; vertical-align: top"&gt;&lt;span style="font-style: normal"&gt;&lt;b&gt;Plus:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1pt; vertical-align: top"&gt;Accretion of carrying value to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--AccretionExpense_c20260101__20260630_zDsagVH0h85g" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;2,784,862&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt; vertical-align: top"&gt;Ordinary shares subject to possible redemption as of June&#160;30, 2026 (Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OrdinarySharesSubjectToPossibleRedemptions_c20260101__20260630_zz1lV8XGkNg1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ordinary shares subject to possible redemptions"&gt;62,882,640&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;







</FVNNU:ScheduleOfOrdinarySharesSubjectToPossibleRedemptionTableTextBlock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000532"
      unitRef="USD">57500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000534"
      unitRef="USD">5010612</us-gaap:ProceedsFromIssuanceOfWarrants>
    <FVNNU:OfferingCostsAllocatedToRedeemableShares
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000536"
      unitRef="USD">-1684693</FVNNU:OfferingCostsAllocatedToRedeemableShares>
    <us-gaap:AccretionExpense
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000538"
      unitRef="USD">9293083</us-gaap:AccretionExpense>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000540"
      unitRef="USD">60097778</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:AccretionExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000542"
      unitRef="USD">2784862</us-gaap:AccretionExpense>
    <FVNNU:OrdinarySharesSubjectToPossibleRedemptions
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000544"
      unitRef="USD">62882640</FVNNU:OrdinarySharesSubjectToPossibleRedemptions>
    <FVNNU:RelatedPartiesPolicyTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000546">&lt;p id="xdx_843_ecustom--RelatedPartiesPolicyTextBlock_zQpzl30OjQUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_861_z37xHPw1pzTj"&gt;&lt;b&gt;Related Parties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or common significant influence.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;








































</FVNNU:RelatedPartiesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000553">&lt;p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zdmOuKOflEJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_865_zMySQsY0HOi5"&gt;&lt;b&gt;Earnings (Loss) Per Ordinary Share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share&#x201d;. The unaudited condensed consolidated statements of operations and comprehensive income include a presentation of earnings (loss) per redeemable share and earnings (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the shares subject to possible redemption was considered to be dividends paid to the public shareholders. For the three and six months ended June&#160;30, 2026 and 2025, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Net income used in the calculation of earnings (loss) per share is as the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfConsolidatedStatementsOfOperationsTableTextBlock_zAWodC2PukBb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B1_zv82iv4mg3Cc" style="display: none"&gt;Schedule of consolidated statements of operations&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20260401__20260630_zpqIoBROM9rg" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20250401__20250630_zoLIfJyYEOGi" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260101__20260630_z1KZGTKctmy5" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250101__20250630_zXfKzgPWrEFa" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Three Months Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;For the&lt;br/&gt; Six Months Ended &lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; padding-left: 0.125in; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; padding-left: 0.125in; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--NetIncomeLoss_zHWY2iQnVkDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;Net income&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;409,985&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;551,900&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;828,741&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;1,006,200&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AccretionOfRedeemableOrdinarySharesSubjectToRedemptionValue_zf2BOSRhKPxd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Less: Accretion of redeemable ordinary shares to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,120,064&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,308,723&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,784,862&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,409,321&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NetLossIncludingAccretionOfRedemmableOrdinarySharesToRedemptionValue_z7gJqU8sObye" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;b&gt;Net loss including accretion of redeemable ordinary shares to redemption value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;(710,079&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;(2,756,823&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;(1,956,121&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;(3,403,121&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;





&lt;p id="xdx_8A9_zuKyoin2RTtg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Earnings (loss) per share presented on the unaudited condensed consolidated statement of operations and comprehensive income for the three months ended June&#160;30, 2026 and 2025 is based on the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z37F6bPGBeVg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BB_zz7rOeyRAMcd" style="display: none"&gt;Schedule of Basic and Diluted Net Loss Per Share&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260401__20260630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryShareMember_zNc7GQrVf599" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20260401__20260630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_z4Ix50J1zhZ6" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250401__20250630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryShareMember_zEUEtvrCFl5c" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20250401__20250630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zDAWh6oNKaWd" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended June&#160;30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--NumeratorsAbstract_iB_zuIcm3G7MIc6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"&gt;Numerators:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--AllocationOfNetLoss_zequ3sdgLAue" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;Allocation of net loss&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(541,219&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(168,860&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(2,101,237&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(655,586&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AccretionOfRedeemableOrdinarySharesToRedemptionValue_zRLisn7hvlqc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Accretion of redeemable ordinary shares to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,120,064&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0585"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,308,723&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0587"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AllocationOfNetincomeLoss_zjZs0DJ9A6D7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Allocation of net&#160;income (loss)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;578,845&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(168,860&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,207,486&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(655,586&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DenominatorAbstract_iB_zJWkdDmWYKxe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"&gt;Denominators:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Weighted-average ordinary shares outstanding&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zlCkueK2yLKi" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_ziWvvWGXMRyd" title="Diluted weighted average ordinary shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zrXMvSwP5rJ4" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zco4lHALhtb8" title="Diluted weighted average ordinary shares outstanding"&gt;1,794,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zxrGurgJ3LGk" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_z2kvWMttB2yl" title="Diluted weighted average ordinary shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zr7LLoq2Bs5j" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zHFWPzw7qfig" title="Diluted weighted average ordinary shares outstanding"&gt;1,794,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted earnings (loss) per share&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zaBaqkf9GQY8" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zj50DY3gK7Bh" title="Diluted earnings per ordinary share"&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareBasic_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zzkk7RJ5ac53" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zSWT1B6NSKgk" title="Diluted earnings per ordinary share"&gt;(0.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zttmA7A02VR9" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_z0qT7r51Nwh5" title="Diluted earnings per ordinary share"&gt;0.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_ze4hJzd6E5i6" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zTtBHGu4WYZ8" title="Diluted earnings per ordinary share"&gt;(0.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;







































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Earnings (loss) per share presented on the unaudited condensed consolidated statement of operations and comprehensive income for the six months ended June&#160;30, 2026 and 2025 is based on the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryShareMember_zeLrTmiWxGD9" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_z04vH5KKKDy4" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20250630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryShareMember_zMAuFs6XfBw9" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20250101__20250630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zQeRe8tjluFe" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the Six Months Ended June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;br/&gt;Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Redeemable&lt;br/&gt;Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;br/&gt;Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--NumeratorsAbstract_iB_zTOPMZS3BR3d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; font-weight: bold"&gt;Numerators:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--AllocationOfNetLoss_z3JtgCjb5kwl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 52%; color: black; text-align: left"&gt;Allocation of net loss&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; color: black; text-align: right"&gt;(1,490,946&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; color: black; text-align: right"&gt;(465,175&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; color: black; text-align: right"&gt;(2,593,842&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; color: black; text-align: right"&gt;(809,279&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AccretionOfRedeemableOrdinarySharesToRedemptionValue_zxSxk9pocuDe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left; padding-bottom: 1pt"&gt;Accretion of redeemable ordinary shares to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,784,862&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0647"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;4,409,321&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0649"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AllocationOfNetincomeLoss_zJ8EWvetwyhf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left; padding-bottom: 2.5pt"&gt;Allocation of net&#160;income (loss)&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;1,293,916&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;(465,175&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;1,815,479&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;(809,279&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DenominatorAbstract_iB_zIaPfMDknIng" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; font-weight: bold"&gt;Denominators:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left; padding-bottom: 2.5pt"&gt;Weighted-average ordinary shares outstanding&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zEfXrAHZ0fTj" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zaP8kfy69wIb" title="Diluted weighted average ordinary shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zJAkp18bFnwg" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_znJzMIT8LBe2" title="Diluted weighted average ordinary shares outstanding"&gt;1,794,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zpROthjtVSkl" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_z0IZhIDdbT9e" title="Diluted weighted average ordinary shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zXPqzxoSePr3" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zNdsxVKDlcTg" title="Diluted weighted average ordinary shares outstanding"&gt;1,794,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted earnings (loss) per share&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zgKEqTNy6qej" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareDiluted_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zjc2dZpfG999" title="Diluted earnings per ordinary share"&gt;0.23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zvGiOSk5nZjj" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zsxAjqQA2Xk2" title="Diluted earnings per ordinary share"&gt;(0.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareBasic_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zzyKrmErY14i" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zUVrm9JtRsd9" title="Diluted earnings per ordinary share"&gt;0.32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_z53F8GZzBOl4" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zqgJQb0tEID6" title="Diluted earnings per ordinary share"&gt;(0.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zqdHtAuYucP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;








</us-gaap:EarningsPerSharePolicyTextBlock>
    <FVNNU:ScheduleOfConsolidatedStatementsOfOperationsTableTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000555">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfConsolidatedStatementsOfOperationsTableTextBlock_zAWodC2PukBb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B1_zv82iv4mg3Cc" style="display: none"&gt;Schedule of consolidated statements of operations&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20260401__20260630_zpqIoBROM9rg" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20250401__20250630_zoLIfJyYEOGi" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260101__20260630_z1KZGTKctmy5" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250101__20250630_zXfKzgPWrEFa" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Three Months Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;For the&lt;br/&gt; Six Months Ended &lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; padding-left: 0.125in; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; padding-left: 0.125in; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--NetIncomeLoss_zHWY2iQnVkDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;Net income&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;409,985&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;551,900&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;828,741&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 9%"&gt;1,006,200&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AccretionOfRedeemableOrdinarySharesSubjectToRedemptionValue_zf2BOSRhKPxd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Less: Accretion of redeemable ordinary shares to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,120,064&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,308,723&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2,784,862&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,409,321&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--NetLossIncludingAccretionOfRedemmableOrdinarySharesToRedemptionValue_z7gJqU8sObye" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;b&gt;Net loss including accretion of redeemable ordinary shares to redemption value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;(710,079&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;(2,756,823&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;(1,956,121&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;(3,403,121&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;





</FVNNU:ScheduleOfConsolidatedStatementsOfOperationsTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000557"
      unitRef="USD">409985</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000558"
      unitRef="USD">551900</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000559"
      unitRef="USD">828741</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000560"
      unitRef="USD">1006200</us-gaap:NetIncomeLoss>
    <FVNNU:AccretionOfRedeemableOrdinarySharesSubjectToRedemptionValue
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000562"
      unitRef="USD">-1120064</FVNNU:AccretionOfRedeemableOrdinarySharesSubjectToRedemptionValue>
    <FVNNU:AccretionOfRedeemableOrdinarySharesSubjectToRedemptionValue
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000563"
      unitRef="USD">-3308723</FVNNU:AccretionOfRedeemableOrdinarySharesSubjectToRedemptionValue>
    <FVNNU:AccretionOfRedeemableOrdinarySharesSubjectToRedemptionValue
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000564"
      unitRef="USD">-2784862</FVNNU:AccretionOfRedeemableOrdinarySharesSubjectToRedemptionValue>
    <FVNNU:AccretionOfRedeemableOrdinarySharesSubjectToRedemptionValue
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000565"
      unitRef="USD">-4409321</FVNNU:AccretionOfRedeemableOrdinarySharesSubjectToRedemptionValue>
    <FVNNU:NetLossIncludingAccretionOfRedemmableOrdinarySharesToRedemptionValue
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000567"
      unitRef="USD">-710079</FVNNU:NetLossIncludingAccretionOfRedemmableOrdinarySharesToRedemptionValue>
    <FVNNU:NetLossIncludingAccretionOfRedemmableOrdinarySharesToRedemptionValue
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000568"
      unitRef="USD">-2756823</FVNNU:NetLossIncludingAccretionOfRedemmableOrdinarySharesToRedemptionValue>
    <FVNNU:NetLossIncludingAccretionOfRedemmableOrdinarySharesToRedemptionValue
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000569"
      unitRef="USD">-1956121</FVNNU:NetLossIncludingAccretionOfRedemmableOrdinarySharesToRedemptionValue>
    <FVNNU:NetLossIncludingAccretionOfRedemmableOrdinarySharesToRedemptionValue
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000570"
      unitRef="USD">-3403121</FVNNU:NetLossIncludingAccretionOfRedemmableOrdinarySharesToRedemptionValue>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000572">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z37F6bPGBeVg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BB_zz7rOeyRAMcd" style="display: none"&gt;Schedule of Basic and Diluted Net Loss Per Share&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20260401__20260630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryShareMember_zNc7GQrVf599" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20260401__20260630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_z4Ix50J1zhZ6" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250401__20250630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryShareMember_zEUEtvrCFl5c" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20250401__20250630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zDAWh6oNKaWd" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended June&#160;30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--NumeratorsAbstract_iB_zuIcm3G7MIc6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"&gt;Numerators:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--AllocationOfNetLoss_zequ3sdgLAue" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;Allocation of net loss&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(541,219&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(168,860&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(2,101,237&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(655,586&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AccretionOfRedeemableOrdinarySharesToRedemptionValue_zRLisn7hvlqc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Accretion of redeemable ordinary shares to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,120,064&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0585"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,308,723&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0587"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AllocationOfNetincomeLoss_zjZs0DJ9A6D7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Allocation of net&#160;income (loss)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;578,845&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(168,860&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,207,486&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(655,586&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DenominatorAbstract_iB_zJWkdDmWYKxe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; vertical-align: top"&gt;Denominators:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Weighted-average ordinary shares outstanding&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zlCkueK2yLKi" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_ziWvvWGXMRyd" title="Diluted weighted average ordinary shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zrXMvSwP5rJ4" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zco4lHALhtb8" title="Diluted weighted average ordinary shares outstanding"&gt;1,794,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zxrGurgJ3LGk" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_z2kvWMttB2yl" title="Diluted weighted average ordinary shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zr7LLoq2Bs5j" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zHFWPzw7qfig" title="Diluted weighted average ordinary shares outstanding"&gt;1,794,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted earnings (loss) per share&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zaBaqkf9GQY8" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zj50DY3gK7Bh" title="Diluted earnings per ordinary share"&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareBasic_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zzkk7RJ5ac53" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20260401__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zSWT1B6NSKgk" title="Diluted earnings per ordinary share"&gt;(0.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zttmA7A02VR9" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_z0qT7r51Nwh5" title="Diluted earnings per ordinary share"&gt;0.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_ze4hJzd6E5i6" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zTtBHGu4WYZ8" title="Diluted earnings per ordinary share"&gt;(0.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;







































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Earnings (loss) per share presented on the unaudited condensed consolidated statement of operations and comprehensive income for the six months ended June&#160;30, 2026 and 2025 is based on the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryShareMember_zeLrTmiWxGD9" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_z04vH5KKKDy4" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20250630__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryShareMember_zMAuFs6XfBw9" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20250101__20250630__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zQeRe8tjluFe" style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the Six Months Ended June 30,&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2026&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Redeemable&lt;br/&gt; Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;br/&gt;Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Redeemable&lt;br/&gt;Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-Redeemable&lt;br/&gt;Ordinary&#160;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--NumeratorsAbstract_iB_zTOPMZS3BR3d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; font-weight: bold"&gt;Numerators:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--AllocationOfNetLoss_z3JtgCjb5kwl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 52%; color: black; text-align: left"&gt;Allocation of net loss&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; color: black; text-align: right"&gt;(1,490,946&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; color: black; text-align: right"&gt;(465,175&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; color: black; text-align: right"&gt;(2,593,842&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="width: 1%; color: black"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; color: black; text-align: right"&gt;(809,279&lt;/td&gt;
    &lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AccretionOfRedeemableOrdinarySharesToRedemptionValue_zxSxk9pocuDe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left; padding-bottom: 1pt"&gt;Accretion of redeemable ordinary shares to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,784,862&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0647"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;4,409,321&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0649"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AllocationOfNetincomeLoss_zJ8EWvetwyhf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left; padding-bottom: 2.5pt"&gt;Allocation of net&#160;income (loss)&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;1,293,916&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;(465,175&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;1,815,479&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;(809,279&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DenominatorAbstract_iB_zIaPfMDknIng" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; font-weight: bold"&gt;Denominators:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left; padding-bottom: 2.5pt"&gt;Weighted-average ordinary shares outstanding&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zEfXrAHZ0fTj" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zaP8kfy69wIb" title="Diluted weighted average ordinary shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zJAkp18bFnwg" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_znJzMIT8LBe2" title="Diluted weighted average ordinary shares outstanding"&gt;1,794,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zpROthjtVSkl" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_z0IZhIDdbT9e" title="Diluted weighted average ordinary shares outstanding"&gt;5,750,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zXPqzxoSePr3" title="Basic weighted average ordinary shares outstanding"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zNdsxVKDlcTg" title="Diluted weighted average ordinary shares outstanding"&gt;1,794,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; color: black; text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted earnings (loss) per share&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zgKEqTNy6qej" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareDiluted_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zjc2dZpfG999" title="Diluted earnings per ordinary share"&gt;0.23&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zvGiOSk5nZjj" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zsxAjqQA2Xk2" title="Diluted earnings per ordinary share"&gt;(0.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareBasic_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zzyKrmErY14i" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--RedeemableOrdinarySharesMember_zUVrm9JtRsd9" title="Diluted earnings per ordinary share"&gt;0.32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_z53F8GZzBOl4" title="Basic earnings per ordinary share"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--NonRedeemableOrdinarySharesMember_zqgJQb0tEID6" title="Diluted earnings per ordinary share"&gt;(0.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <FVNNU:AllocationOfNetLoss
      contextRef="From2026-04-012026-06-30_custom_RedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000579"
      unitRef="USD">-541219</FVNNU:AllocationOfNetLoss>
    <FVNNU:AllocationOfNetLoss
      contextRef="From2026-04-012026-06-30_custom_NonRedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000580"
      unitRef="USD">-168860</FVNNU:AllocationOfNetLoss>
    <FVNNU:AllocationOfNetLoss
      contextRef="From2025-04-012025-06-30_custom_RedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000581"
      unitRef="USD">-2101237</FVNNU:AllocationOfNetLoss>
    <FVNNU:AllocationOfNetLoss
      contextRef="From2025-04-012025-06-30_custom_NonRedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000582"
      unitRef="USD">-655586</FVNNU:AllocationOfNetLoss>
    <FVNNU:AccretionOfRedeemableOrdinarySharesToRedemptionValue
      contextRef="From2026-04-012026-06-30_custom_RedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000584"
      unitRef="USD">1120064</FVNNU:AccretionOfRedeemableOrdinarySharesToRedemptionValue>
    <FVNNU:AccretionOfRedeemableOrdinarySharesToRedemptionValue
      contextRef="From2025-04-012025-06-30_custom_RedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000586"
      unitRef="USD">3308723</FVNNU:AccretionOfRedeemableOrdinarySharesToRedemptionValue>
    <FVNNU:AllocationOfNetincomeLoss
      contextRef="From2026-04-012026-06-30_custom_RedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000589"
      unitRef="USD">578845</FVNNU:AllocationOfNetincomeLoss>
    <FVNNU:AllocationOfNetincomeLoss
      contextRef="From2026-04-012026-06-30_custom_NonRedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000590"
      unitRef="USD">-168860</FVNNU:AllocationOfNetincomeLoss>
    <FVNNU:AllocationOfNetincomeLoss
      contextRef="From2025-04-012025-06-30_custom_RedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000591"
      unitRef="USD">1207486</FVNNU:AllocationOfNetincomeLoss>
    <FVNNU:AllocationOfNetincomeLoss
      contextRef="From2025-04-012025-06-30_custom_NonRedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000592"
      unitRef="USD">-655586</FVNNU:AllocationOfNetincomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-04-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000599"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-04-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000601"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-04-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000603"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-04-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000605"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-04-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000607"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-04-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000609"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-04-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000611"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-04-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000613"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-04-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000615"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-04-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000617"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-04-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000619"
      unitRef="USDPShares">-0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-04-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000621"
      unitRef="USDPShares">-0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-04-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000623"
      unitRef="USDPShares">0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-04-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000625"
      unitRef="USDPShares">0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-04-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000627"
      unitRef="USDPShares">-0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-04-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000629"
      unitRef="USDPShares">-0.37</us-gaap:EarningsPerShareDiluted>
    <FVNNU:AllocationOfNetLoss
      contextRef="From2026-01-012026-06-30_custom_RedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000641"
      unitRef="USD">-1490946</FVNNU:AllocationOfNetLoss>
    <FVNNU:AllocationOfNetLoss
      contextRef="From2026-01-012026-06-30_custom_NonRedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000642"
      unitRef="USD">-465175</FVNNU:AllocationOfNetLoss>
    <FVNNU:AllocationOfNetLoss
      contextRef="From2025-01-012025-06-30_custom_RedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000643"
      unitRef="USD">-2593842</FVNNU:AllocationOfNetLoss>
    <FVNNU:AllocationOfNetLoss
      contextRef="From2025-01-012025-06-30_custom_NonRedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000644"
      unitRef="USD">-809279</FVNNU:AllocationOfNetLoss>
    <FVNNU:AccretionOfRedeemableOrdinarySharesToRedemptionValue
      contextRef="From2026-01-012026-06-30_custom_RedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000646"
      unitRef="USD">2784862</FVNNU:AccretionOfRedeemableOrdinarySharesToRedemptionValue>
    <FVNNU:AccretionOfRedeemableOrdinarySharesToRedemptionValue
      contextRef="From2025-01-012025-06-30_custom_RedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000648"
      unitRef="USD">4409321</FVNNU:AccretionOfRedeemableOrdinarySharesToRedemptionValue>
    <FVNNU:AllocationOfNetincomeLoss
      contextRef="From2026-01-012026-06-30_custom_RedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000651"
      unitRef="USD">1293916</FVNNU:AllocationOfNetincomeLoss>
    <FVNNU:AllocationOfNetincomeLoss
      contextRef="From2026-01-012026-06-30_custom_NonRedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000652"
      unitRef="USD">-465175</FVNNU:AllocationOfNetincomeLoss>
    <FVNNU:AllocationOfNetincomeLoss
      contextRef="From2025-01-012025-06-30_custom_RedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000653"
      unitRef="USD">1815479</FVNNU:AllocationOfNetincomeLoss>
    <FVNNU:AllocationOfNetincomeLoss
      contextRef="From2025-01-012025-06-30_custom_NonRedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000654"
      unitRef="USD">-809279</FVNNU:AllocationOfNetincomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-01-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000661"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-01-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000663"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-01-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000665"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-01-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000667"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000669"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-01-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000671"
      unitRef="Shares">5750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000673"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-01-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000675"
      unitRef="Shares">1794000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-01-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000677"
      unitRef="USDPShares">0.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-01-012026-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000679"
      unitRef="USDPShares">0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-01-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000681"
      unitRef="USDPShares">-0.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-01-012026-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000683"
      unitRef="USDPShares">-0.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-01-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000685"
      unitRef="USDPShares">0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-01-012025-06-30_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000687"
      unitRef="USDPShares">0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-01-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000689"
      unitRef="USDPShares">-0.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-01-012025-06-30_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000691"
      unitRef="USDPShares">-0.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000693">&lt;p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zqlTlJfrPmKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86B_z1Xo2tEl8jJj"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for income taxes under ASC 740 Income Taxes (&#x201c;ASC 740&#x201d;). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were &lt;span id="xdx_905_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20260630_zmuA6o1LZ9uc"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20260630_z26xEHHe5AQ8"&gt;no&lt;/span&gt; amounts accrued for interest and penalties as of June&#160;30, 2026 and December&#160;31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company determined that the Cayman Islands is the Company&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2019;&lt;/span&gt;s only major tax jurisdiction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company may be subject to potential examination by taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2019;&lt;/span&gt;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There is currently no taxation imposed on income by the Government of the Cayman Islands for the three and six months ended June&#160;30, 2026 and 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





































</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000694"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000695"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000702">&lt;p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z8T7TTsw6I93" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_864_zhckjOtjxLil"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2024, the FASB issued ASU 2024-03, Income Statement &lt;span style="font-family: DengXian"&gt;&#x2014;&lt;/span&gt; Reporting Comprehensive Income &lt;span style="font-family: DengXian"&gt;&#x2014;&lt;/span&gt; Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (&lt;span style="font-family: DengXian"&gt;&#x201c;&lt;/span&gt;ASU 2024-03&lt;span style="font-family: DengXian"&gt;&#x201d;&lt;/span&gt;) which requires detailed disclosures in the notes to financial statements disaggregating specific expense categories and certain other disclosures to provide enhanced transparency into the nature and function of expenses. The FASB further clarified the effective date in January 2025 with the issuance of ASU 2025-01, Income Statement &lt;span style="font-family: DengXian"&gt;&#x2014;&lt;/span&gt; Reporting Comprehensive Income &lt;span style="font-family: DengXian"&gt;&#x2014;&lt;/span&gt; Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date (&lt;span style="font-family: DengXian"&gt;&#x201c;&lt;/span&gt;ASU 2025-01&lt;span style="font-family: DengXian"&gt;&#x201d;&lt;/span&gt;). ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The requirements should be applied on a prospective basis while retrospective application is permitted. The Company does not expect to adopt this guidance early and does not expect the adoption of this ASU to have a material impact on its condensed consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 8, 2025, the FASB issued ASU 2025-11 &lt;span style="font-family: DengXian"&gt;&#x2014;&lt;/span&gt; Interim Reporting (&lt;span style="font-family: DengXian"&gt;&#x201c;&lt;/span&gt;ASU 2025-11&lt;span style="font-family: DengXian"&gt;&#x201d;&lt;/span&gt;) which is intended to improve the navigability of the guidance in ASC 270, Interim Reporting, and clarify when it applies. Under the amendments, an entity is subject to ASC 270 if it provides interim financial statements and notes in accordance with GAAP. ASU 2025-11 also addresses the form and content of such financial statements, interim disclosures requirements, and establishes a principle under which an entity must disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, and early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2025-11 may have on its condensed consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management does not believe that any recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2019;&lt;/span&gt;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;





</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <FVNNU:ProposedPublicOfferingTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000704">&lt;p id="xdx_80D_ecustom--ProposedPublicOfferingTextBlock_z6ShUNSbRepg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 3 &#x2014; &lt;span id="xdx_827_zF7PxpBVUoul"&gt;Initial Public Offering&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 13, 2024, the Company consummated its IPO of &lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240901__20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zVk1YWAvsy4d" title="Sale of units in public offering"&gt;5,000,000&lt;/span&gt; Units, at $&lt;span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z1Oou6gmEpml" title="Sale of units per share"&gt;10.00&lt;/span&gt; per Unit, generating gross proceeds of $&lt;span id="xdx_90C_ecustom--ProceedsFromIssuanceInitialPublicOfferings_c20240901__20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zgV7tGorE3zk" title="Proceeds from issuance of initial public offering"&gt;50,000,000&lt;/span&gt;. The Company granted the underwriter a 45-day option to purchase up to an additional &lt;span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240901__20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zChijTyXlm4h" title="Sale of units in public offering"&gt;750,000&lt;/span&gt; Units at the IPO price to cover over-allotments. On September 13, 2024, the over-allotment option was exercised, generating gross proceeds of $&lt;span id="xdx_909_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20240901__20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zFPIUbrZvwn2" title="Proceeds from issuance of initial public offering"&gt;7,500,000&lt;/span&gt; and deposited into the Trust Account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Each unit has an offering price of $&lt;span id="xdx_907_ecustom--OfferingPrice_iI_c20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6LBW5FIdane" title="Offering price"&gt;10.00&lt;/span&gt; and consists of one ordinary share (&#x201c;Public Share&#x201d;) and one right (&#x201c;Public Right&#x201d;) to receive one-tenth (1/10) of an ordinary share upon the consummation of the initial Business Combination.&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Meanwhile, the Company incurred offering costs of approximately $&lt;span id="xdx_909_ecustom--OfferingCosts_c20260101__20260630_z7Y8OkhYgKsb" title="Offering costs"&gt;1,845,513&lt;/span&gt;, consisting of $&lt;span id="xdx_909_ecustom--Consisting_c20260101__20260630_z4OAOrpQgjji" title="Consisting"&gt;862,500&lt;/span&gt; and $&lt;span id="xdx_907_ecustom--UnderwritingCommissions_c20260101__20260630_zugM17WaKwt" title="Underwriting commissions"&gt;522,019&lt;/span&gt; of underwriting commissions which were paid in cash and representative shares (57,500 ordinary shares) at the closing date of the IPO, respectively and $&lt;span id="xdx_907_ecustom--OtherOfferingCosts_c20260101__20260630_zaAlQSrKMNia" title="Other offering costs"&gt;460,994&lt;/span&gt; of other offering costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Meanwhile, pursuant the underwriting agreement, 1.0% of the gross proceeds of the IPO, or $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20260101__20260630_zZ52zq8Lqbtb" title="Gross proceeds of the IPO"&gt;575,000&lt;/span&gt;, will be paid in cash, and &lt;span id="xdx_905_eus-gaap--SharesIssued_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RepresentativeSharesMember_zZdgZOPn8Ro2" title="Shares issued"&gt;28,750&lt;/span&gt; representative shares will be issued, both of which as the deferred underwriting commission at the consummation of a Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All of the&#160;&lt;span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260101__20260630_zvlheHCr9Kv2" title="Public shares sold"&gt;5,750,000&lt;/span&gt;&#160;public shares sold as part of the Public Units in the IPO contain a redemption feature and the Company has classified related proceeds in temporary equity as disclosed in Note 2.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;







































</FVNNU:ProposedPublicOfferingTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-09-012024-09-13_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000706"
      unitRef="Shares">5000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-09-13_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000708"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <FVNNU:ProceedsFromIssuanceInitialPublicOfferings
      contextRef="From2024-09-012024-09-13_us-gaap_IPOMember"
      decimals="0"
      id="Fact000710"
      unitRef="USD">50000000</FVNNU:ProceedsFromIssuanceInitialPublicOfferings>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-09-012024-09-13_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember"
      decimals="INF"
      id="Fact000712"
      unitRef="Shares">750000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2024-09-012024-09-13_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000714"
      unitRef="USD">7500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <FVNNU:OfferingPrice
      contextRef="AsOf2024-09-13_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000716"
      unitRef="USDPShares">10.00</FVNNU:OfferingPrice>
    <FVNNU:OfferingCosts
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000718"
      unitRef="USD">1845513</FVNNU:OfferingCosts>
    <FVNNU:Consisting
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000720"
      unitRef="USD">862500</FVNNU:Consisting>
    <FVNNU:UnderwritingCommissions
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000722"
      unitRef="USD">522019</FVNNU:UnderwritingCommissions>
    <FVNNU:OtherOfferingCosts
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000724"
      unitRef="USD">460994</FVNNU:OtherOfferingCosts>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000726"
      unitRef="USD">575000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SharesIssued
      contextRef="AsOf2026-06-30_custom_RepresentativeSharesMember"
      decimals="INF"
      id="Fact000728"
      unitRef="Shares">28750</us-gaap:SharesIssued>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-01-01to2026-06-30"
      decimals="INF"
      id="Fact000730"
      unitRef="Shares">5750000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <FVNNU:PrivatePlacementTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000737">&lt;p id="xdx_808_ecustom--PrivatePlacementTextBlock_zP0xl8AKUeKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 4 &#x2014; &lt;span id="xdx_825_zTWsbtLh4Qqc"&gt; Private Placement&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of &lt;span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zkbZa5SL9whl" title="Sale of units in public offering"&gt;299,000&lt;/span&gt; Placement Units at a price of $&lt;span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zXPfyGmJi0S6" title="Sale of units per share"&gt;10.00&lt;/span&gt; per Placement Unit raising $&lt;span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zdTdXSLBI025" title="Proceeds from sale of private placements"&gt;2,990,000&lt;/span&gt; in the aggregate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The proceeds from the sale of the Placement Units were added to the net proceeds from the IPO held in the Trust Account. The Private Placement Units are identical to the Public Units sold in this IPO, subject to limited exceptions. The holder of the Private Placement Units will be entitled to registration rights. In addition, these Private Placement Units may not, subject to certain limited exceptions, be redeemable, transferred, assigned or sold until the later of the completion of our initial Business Combination or 12 months following the closing of the IPO.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;





</FVNNU:PrivatePlacementTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-01-012026-06-30_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000739"
      unitRef="Shares">299000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-06-30_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000741"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2026-01-012026-06-30_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact000743"
      unitRef="USD">2990000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000745">&lt;p id="xdx_80D_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zy0r4hj86xql" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 5 &#x2014; &lt;span id="xdx_824_z6tiKHc87509"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Nature of relationship with the related party:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following is a list of the related party, with which the Company has transactions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 6%; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;No.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: left; width: 45%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Name of Related Parties &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: left; width: 45%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Relationship&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;HWei Super Speed Co. Ltd.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Founder and sponsor of the Company&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Transactions with the related party:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;(i) Founder Shares&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February&#160;27, 2024, the Sponsor acquired &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240201__20240227__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z2vQ9ZCKGTq1" title="Number of shares issued"&gt;1,437,500&lt;/span&gt; ordinary shares (&#x201c;Founder shares&#x201d;) for an aggregate purchase price of $&lt;span id="xdx_900_ecustom--AggregatedPurchasePrice_c20240201__20240227__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zf3mhKDlBYm2" title="Aggregated purchase price"&gt;25,000&lt;/span&gt;, among which, up to &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240201__20240227__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zg21WeRWlyu2" title="Number of shares issued"&gt;187,500&lt;/span&gt; Founder Shares are subject to forfeiture if the underwriters&#x2019; over-allotment is not exercised. On September&#160;13, 2024, the over-allotment option was exercised and none of the Founder Shares were subject to forfeiture.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Sponsor has agreed not to transfer, assign or sell their Founder Shares (excluding any units or shares comprising the units acquired in the offering) until the earlier to occur of (a) twelve months after the completion of the Company&#x2019;s initial Business Combination and (b) upon completion of the Company&#x2019;s initial Business Combination, (x) if the last reported sale price of the Company&#x2019;s ordinary shares equals or exceeds $12.00 per unit (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company&#x2019;s initial Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after the Company&#x2019;s initial Business Combination that results in all of the Company&#x2019;s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Any permitted transferees would be subject to the same restrictions and other agreements of our sponsor, directors and executive officers with respect to any Founder Shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;(ii) Promissory Note &#x2014; Related Party (IPO)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February&#160;22, 2024, the Company issued a promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20240222_ztUa7LF2Mkhd" title="Aggregate principal amount"&gt;500,000&lt;/span&gt; (the &#x201c;Promissory Note&#x201d;) to be used for a portion of the expenses for the IPO. This loan is non-interest bearing, unsecured and is due at the earlier of (1) September&#160;30, 2024 or (2) the closing of the IPO. The loan will be repaid upon the closing of the IPO out of the offering proceeds not held in the Trust Account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the period from January 30, 2024 (inception) through December 31, 2024, the Company had borrowed $&lt;span id="xdx_907_eus-gaap--RepaymentOfNotesReceivableFromRelatedParties_pp0p0_c20250101__20250630_zoXc60vFuTy7"&gt;375,000 &lt;/span&gt;under the Promissory Note with the Sponsor for its IPO. Shortly after completion of the IPO, such amount was fully repaid.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;(iii) Promissory Note &#x2014; Related Party (Extension)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 4, 2026, April 7, 2026, May 7, 2026, June 7, 2026 and July 7, 2026, the Company&#x2019;s Board of Directors approved the First, Second, Third, Fourth and Fifth Extensions, respectively, extending the deadline to consummate a Business Combination from March 13, 2026 to April&#160;13, 2026, from April 13, 2026 to May 13, 2026, from May 13, 2026 to June 13, 2026, from June 13, 2026 to July 13, 2026, and from July 13, 2026 to August 13, 2026, respectively. On March 9, 2026, April 11, 2026, May 11, 2026, June 11, 2026 and July 13, 2026, in connection with each Extension, the Company issued an unsecured promissory note to the Sponsor in the principal amount of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20260630_zW5I4TAonDHl" title="Principal amount"&gt;191,475&lt;/span&gt; each (collectively the &#x201c;Extension Promissory Notes&#x201d;). The Extension Promissory Notes bear no interest and are payable on the earlier of: (i) the consummation of the Company&#x2019;s initial Business Combination, or (ii) the date the Company is wound up and liquidates. If the Company fails to consummate a Business Combination by the expiration of its prescribed timeframe and liquidates, the Extension Promissory Notes will be forgiven and the Sponsor will have no right to payment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;At the Sponsor&#x2019;s option, prior to full repayment, all or any portion of the unpaid principal may be converted into units of the Company at $10.00 per unit upon consummation of a Business Combination. The conversion units are identical to the Placement Units issued to the Sponsor in the private placement concurrent with the Company&#x2019;s IPO. The Sponsor&#x2019;s conversion right, when aggregated with other similar working capital or extension loans, shall not exceed $&lt;span id="xdx_905_ecustom--AggregatePrincipal_iI_c20260630_zeJJWc8Ghnn6" title="Aggregate principal"&gt;1,500,000&lt;/span&gt; in aggregate principal.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Sponsor has waived any claim to or from the Trust Account and agreed not to seek recourse against the Trust Account for any reason. An event of default occurs if the Company fails to pay within five business days of the due date or commences voluntary bankruptcy proceedings.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2026, the proceeds of the Extension Promissory Notes of $&lt;span id="xdx_905_eus-gaap--Deposits_iI_c20260630_zid9wuUguY84" title="Deposits"&gt;191,475&lt;/span&gt; each (aggregating $765,900 in total) were deposited directly into the Company&#x2019;s Trust Account to fund the corresponding Extensions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;(iv) Working Capital Loans&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In addition, in order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor, the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes the initial Business Combination, it intends to repay such loaned amount at closing. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to $&lt;span id="xdx_907_ecustom--WorkingCapitalLoans_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zup9zOVUs9qk" title="Working capital loans"&gt;1,500,000&lt;/span&gt; of such working capital loans (&#x201c;Working Capital Loans&#x201d;) made by the Sponsor, the Company&#x2019;s officers and directors, or the Company&#x2019;s or their affiliates to the Company prior to or in connection with its initial Business Combination may be convertible into units, at a price of $10.00 per unit at the option of the lender, upon consummation of its initial Business Combination. The units would be identical to the Placement Units.&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the three and six months ended June 30, 2026 and 2025, the Company had &lt;span id="xdx_901_ecustom--WorkingCapitalLoans_iI_do_c20260630_zhxYrf0Rf5Yk" title="Working capital loans"&gt;&lt;span id="xdx_904_ecustom--WorkingCapitalLoans_iI_do_c20250630_zGjaunXdC0f7" title="Working capital loans"&gt;no&lt;/span&gt;&lt;/span&gt; borrowings under the Working Capital Loans.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;(v) Administrative Services Arrangement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Commencing on the effective date of the registration statement of the IPO, the Company has agreed to pay an affiliate of the Sponsor a total of $&lt;span id="xdx_908_eus-gaap--GeneralAndAdministrativeExpense_c20260101__20260630_z5otFLuKttB" title="General and administrative expense"&gt;10,000&lt;/span&gt; per month for office space, utilities and secretarial and administrative support. Upon completion of its initial Business Combination or its liquidation, the Company will cease paying these monthly fees. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the three months ended June 30, 2026 and 2025, the Company has accrued $&lt;span id="xdx_90D_eus-gaap--AdministrativeFeesExpense_pp0p0_c20260401__20260630_zp6CzHX5xYXj"&gt;30,333&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--AdministrativeFeesExpense_pp0p0_c20250401__20250630_zn2E3ekOoHV5"&gt;30,333&lt;/span&gt; for the service provided by the Sponsor, respectively. For the six months ended June 30, 2026 and 2025, the Company has accrued $&lt;span id="xdx_903_eus-gaap--AdministrativeFeesExpense_pp0p0_c20260101__20260630_zKzSliAvd4l3"&gt;60,333&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--AdministrativeFeesExpense_pp0p0_c20250101__20250630_zPmPrrz35Zw2"&gt;60,333&lt;/span&gt; for the service provided by the Sponsor, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Balance with the related party:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zxTjC2KSLkUi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B3_zJeqSSPil24k" style="display: none"&gt;Schedule of related party&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June&#160;30,&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2026&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Amount due to a related party:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Related party&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; font-weight: bold"&gt;Nature&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left"&gt;HWei Super Speed Co. Ltd.&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 35%; text-align: left"&gt;Administrative support service fee&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--DueToRelatedParties_iI_c20260630__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportServiceFeeMember_zHs7G55fdPM2" style="width: 9%; text-align: right" title="Due to related parties"&gt;218,333&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DueToRelatedParties_iI_c20251231__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportServiceFeeMember_zXOS7vVgwl15" style="width: 9%; text-align: right" title="Due to related parties"&gt;158,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;HWei Super Speed Co. Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Promissory note for extension&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--DueToRelatedParties_iI_c20260630__us-gaap--RelatedPartyTransactionAxis__custom--PromissoryNoteForExtensionMember_zTTRonWATM26" style="text-align: right" title="Due to related parties"&gt;765,900&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--DueToRelatedParties_iI_c20251231__us-gaap--RelatedPartyTransactionAxis__custom--PromissoryNoteForExtensionMember_zOYdOFgbgkz3" style="text-align: right" title="Due to related parties"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0792"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The amount due to the related party is non-interest bearing and due on demand.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;





</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-012024-02-27_custom_SponsorMember"
      decimals="INF"
      id="Fact000747"
      unitRef="Shares">1437500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <FVNNU:AggregatedPurchasePrice
      contextRef="From2024-02-012024-02-27_custom_SponsorMember"
      decimals="0"
      id="Fact000749"
      unitRef="USD">25000</FVNNU:AggregatedPurchasePrice>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-012024-02-27_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000751"
      unitRef="Shares">187500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-02-22"
      decimals="0"
      id="Fact000753"
      unitRef="USD">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentOfNotesReceivableFromRelatedParties
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000754"
      unitRef="USD">375000</us-gaap:RepaymentOfNotesReceivableFromRelatedParties>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000761"
      unitRef="USD">191475</us-gaap:DebtInstrumentFaceAmount>
    <FVNNU:AggregatePrincipal
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000763"
      unitRef="USD">1500000</FVNNU:AggregatePrincipal>
    <us-gaap:Deposits
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000765"
      unitRef="USD">191475</us-gaap:Deposits>
    <FVNNU:WorkingCapitalLoans
      contextRef="AsOf2026-06-30_custom_SponsorMember"
      decimals="0"
      id="Fact000767"
      unitRef="USD">1500000</FVNNU:WorkingCapitalLoans>
    <FVNNU:WorkingCapitalLoans
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000769"
      unitRef="USD">0</FVNNU:WorkingCapitalLoans>
    <FVNNU:WorkingCapitalLoans
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000771"
      unitRef="USD">0</FVNNU:WorkingCapitalLoans>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000773"
      unitRef="USD">10000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000774"
      unitRef="USD">30333</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000775"
      unitRef="USD">30333</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000776"
      unitRef="USD">60333</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000777"
      unitRef="USD">60333</us-gaap:AdministrativeFeesExpense>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000784">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zxTjC2KSLkUi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B3_zJeqSSPil24k" style="display: none"&gt;Schedule of related party&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June&#160;30,&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2026&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Amount due to a related party:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Related party&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; font-weight: bold"&gt;Nature&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left"&gt;HWei Super Speed Co. Ltd.&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 35%; text-align: left"&gt;Administrative support service fee&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--DueToRelatedParties_iI_c20260630__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportServiceFeeMember_zHs7G55fdPM2" style="width: 9%; text-align: right" title="Due to related parties"&gt;218,333&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DueToRelatedParties_iI_c20251231__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeSupportServiceFeeMember_zXOS7vVgwl15" style="width: 9%; text-align: right" title="Due to related parties"&gt;158,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;HWei Super Speed Co. Ltd.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Promissory note for extension&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--DueToRelatedParties_iI_c20260630__us-gaap--RelatedPartyTransactionAxis__custom--PromissoryNoteForExtensionMember_zTTRonWATM26" style="text-align: right" title="Due to related parties"&gt;765,900&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--DueToRelatedParties_iI_c20251231__us-gaap--RelatedPartyTransactionAxis__custom--PromissoryNoteForExtensionMember_zOYdOFgbgkz3" style="text-align: right" title="Due to related parties"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0792"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <FVNNU:DueToRelatedParties
      contextRef="AsOf2026-06-30_custom_AdministrativeSupportServiceFeeMember"
      decimals="0"
      id="Fact000786"
      unitRef="USD">218333</FVNNU:DueToRelatedParties>
    <FVNNU:DueToRelatedParties
      contextRef="AsOf2025-12-31_custom_AdministrativeSupportServiceFeeMember"
      decimals="0"
      id="Fact000788"
      unitRef="USD">158000</FVNNU:DueToRelatedParties>
    <FVNNU:DueToRelatedParties
      contextRef="AsOf2026-06-30_custom_PromissoryNoteForExtensionMember"
      decimals="0"
      id="Fact000790"
      unitRef="USD">765900</FVNNU:DueToRelatedParties>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000794">&lt;p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zDWEYPFan5Dl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 6 &#x2014; &lt;span id="xdx_82F_zE94dIpQDFT1"&gt;Shareholder&#x2019;s Equity&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Ordinary Shares&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is authorized to issue &lt;span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_c20260630_zGZG5ws9lZZe" title="Common stock, shares authorized"&gt;500,000,000&lt;/span&gt; ordinary shares with a par value of $&lt;span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20260630_zIVHSZ4UYgH8" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share. On January&#160;30, 2024, the Company issued &lt;span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_c20240129__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zw2kOvi8UIN5" title="Ordinary shares issued"&gt;10,000&lt;/span&gt; ordinary shares to the Sponsor for an aggregate purchase price of $&lt;span id="xdx_908_ecustom--AggregatePurchasePrice_c20240101__20240129_zu4L1uuLkgwe" title="Aggregate purchase price"&gt;1&lt;/span&gt;. On February&#160;27, 2024, the Company issued &lt;span id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_c20240227__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zaV7cDZ1xn5g" title="Ordinary shares issued"&gt;1,437,500&lt;/span&gt; ordinary shares to the Sponsor including an aggregate of &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20240201__20240227__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zEePYeaQg8yj" title="Forfeiture shares"&gt;187,500&lt;/span&gt; shares that are subject to forfeiture to the extent that the underwriter&#x2019;s over-allotment option is not exercised in full or in part, so that the initial shareholder will own 20% of the Company&#x2019;s issued and outstanding ordinary shares (excluding the Private Placement shares and Representative shares (as described below) and assuming the initial shareholder does not purchase any shares in the IPO). Meanwhile, the Sponsor irrevocably surrendered to the Company for cancellation and for nil consideration &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20260630_zWX68XpuIxq1" title="Cancellation of shares"&gt;10,000&lt;/span&gt; ordinary shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On September&#160;13, 2024, the Company consummated its IPO of &lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240901__20240913_zXy6XmCab959" title="Sale of units in public offering"&gt;5,000,000&lt;/span&gt; units at $10.00 per Unit, with the exercise of the underwriter&#x2019;s over-allotment option of &lt;span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240901__20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zujE0WRAvny" title="Sale of units in public offering"&gt;750,000&lt;/span&gt; units, generating gross proceeds of $&lt;span id="xdx_90E_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20240901__20240913_zUDGc6F0F62d" title="Gross proceeds"&gt;57,500,000&lt;/span&gt;. As a result, the &lt;span id="xdx_90C_ecustom--OrdinaryShares_iI_c20240913_zl616hdlInQ7" title="Ordinary shares"&gt;187,500&lt;/span&gt; ordinary shares of founder shares were no longer subject to forfeiture.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Simultaneously with the consummation of the closing of the IPO, the Company issued &lt;span id="xdx_900_ecustom--IssuanceInitialPublicOffering_c20240901__20240913__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember_zvesubXcjg62" title="IPO Company issued"&gt;299,000&lt;/span&gt; ordinary shares to the Sponsor in the private placement.&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On September&#160;13, 2024, the Company issued &lt;span id="xdx_90F_eus-gaap--SharesIssued_iI_c20240913_zSMEkdphLUzd" title="Shares issued"&gt;57,500&lt;/span&gt; Representative Shares to the representative of the underwriters (and/or its designees) as part of the underwriting compensation. The representative shares have deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the commencement of sales in this offering pursuant to FINRA Rule&#160;5110I(1). Pursuant to FINRA Rule&#160;5110I(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the commencement of sales in this offering, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following September&#160;13, 2024 except to any underwriter and selected dealer participating in the offering and their officers, partners, registered persons or affiliates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2026 and December 31, 2025, as a result of closing of the IPO, the exercise of the Representative&#x2019;s Over-Allotment Option and the sales of Placement Units in the private placement, there were &lt;span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20240913_zesaCOVexuTe" title="Ordinary shares outstanding"&gt;7,544,000&lt;/span&gt; ordinary shares issued and outstanding, including &lt;span id="xdx_90E_ecustom--OrdinarySharesSubjectToPossibleRedemption_iI_c20240913_zRAStddLqJ5d" title="Ordinary shares subject to possible redemption"&gt;5,750,000&lt;/span&gt; ordinary shares subject to possible redemption, which are classified as temporary equity, and &lt;span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zF4UAl87va86" title="Ordinary shares issued"&gt;1,794,000&lt;/span&gt; ordinary shares. &lt;span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zuVwPoSVC7L3" title="Ordinary shares outstanding"&gt;1,794,000&lt;/span&gt; ordinary shares issued and outstanding, consisting of &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_ztx9txZtfwEd" title="Number of shares exercised"&gt;1,437,500&lt;/span&gt; ordinary shares of founder shares, 299,000 ordinary shares from private placement and &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_z1NITKTX0pIh" title="Number of shares exercised"&gt;57,500&lt;/span&gt; ordinary shares to the underwriter.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Rights&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2026 and December&#160;31, 2025, there were &lt;span id="xdx_902_ecustom--PublicRights_iI_c20260630_zYWxeI4mlDdh" title="Public rights"&gt;&lt;span id="xdx_906_ecustom--PublicRights_iI_c20251231_zPLvm7tSCM57" title="Public rights"&gt;5,750,000&lt;/span&gt;&lt;/span&gt; public rights included in the Public Units and &lt;span id="xdx_90E_ecustom--PrivateRights_iI_c20260630_zKdSprFF5byb" title="Private rights"&gt;&lt;span id="xdx_901_ecustom--PrivateRights_iI_c20251231_zRwgbGbMDVy3" title="Private rights"&gt;299,000&lt;/span&gt;&lt;/span&gt; private rights include in the Placement Units outstanding. There was no right attached to the Representative Shares. Except in cases where the Company is not the surviving company in a Business Combination, each holder of a right will receive one-tenth (1/10) of an ordinary share (the &#x201c;Rights&#x201d;) upon consummation of the initial Business Combination. In the event the Company will not be the surviving company upon completion of our initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth (1/10) of a share of the Company underlying each right upon consummation of the Business Combination unless otherwise waived in the course of the Business Combination. No fractional shares will be issued upon exchange of rights. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a Business Combination. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman Law. If the Company is unable to complete an initial Business Combination within the required time period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company&#x2019;s assets held outside of the Trust Account with respect to such Rights, and the Rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the Rights upon consummation of an initial Business Combination. Accordingly, the Rights may expire worthless.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000796"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000798"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-01-29_custom_SponsorMember"
      decimals="INF"
      id="Fact000800"
      unitRef="Shares">10000</us-gaap:CommonStockSharesIssued>
    <FVNNU:AggregatePurchasePrice
      contextRef="From2024-01-012024-01-29"
      decimals="0"
      id="Fact000802"
      unitRef="USD">1</FVNNU:AggregatePurchasePrice>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-02-27_custom_SponsorMember"
      decimals="INF"
      id="Fact000804"
      unitRef="Shares">1437500</us-gaap:CommonStockSharesIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2024-02-012024-02-27_custom_SponsorMember"
      decimals="INF"
      id="Fact000806"
      unitRef="Shares">187500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000808"
      unitRef="Shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-09-012024-09-13"
      decimals="INF"
      id="Fact000810"
      unitRef="Shares">5000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-09-012024-09-13_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember"
      decimals="INF"
      id="Fact000812"
      unitRef="Shares">750000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2024-09-012024-09-13"
      decimals="0"
      id="Fact000814"
      unitRef="USD">57500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <FVNNU:OrdinaryShares
      contextRef="AsOf2024-09-13"
      decimals="INF"
      id="Fact000816"
      unitRef="Shares">187500</FVNNU:OrdinaryShares>
    <FVNNU:IssuanceInitialPublicOffering
      contextRef="From2024-09-012024-09-13_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000818"
      unitRef="Shares">299000</FVNNU:IssuanceInitialPublicOffering>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-09-13"
      decimals="INF"
      id="Fact000820"
      unitRef="Shares">57500</us-gaap:SharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-09-13"
      decimals="INF"
      id="Fact000822"
      unitRef="Shares">7544000</us-gaap:CommonStockSharesOutstanding>
    <FVNNU:OrdinarySharesSubjectToPossibleRedemption
      contextRef="AsOf2024-09-13"
      decimals="INF"
      id="Fact000824"
      unitRef="Shares">5750000</FVNNU:OrdinarySharesSubjectToPossibleRedemption>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-06-30_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000826"
      unitRef="Shares">1794000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-06-30_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000828"
      unitRef="Shares">1794000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2026-01-012026-06-30_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000830"
      unitRef="Shares">1437500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2026-01-012026-06-30_custom_UnderwritersMember"
      decimals="INF"
      id="Fact000832"
      unitRef="Shares">57500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <FVNNU:PublicRights
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000839"
      unitRef="Shares">5750000</FVNNU:PublicRights>
    <FVNNU:PublicRights
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000841"
      unitRef="Shares">5750000</FVNNU:PublicRights>
    <FVNNU:PrivateRights
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000843"
      unitRef="Shares">299000</FVNNU:PrivateRights>
    <FVNNU:PrivateRights
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000845"
      unitRef="Shares">299000</FVNNU:PrivateRights>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000847">&lt;p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z9bOQ3ME0gB1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note
7 &#x2014; &lt;span id="xdx_829_zwfF6Nulqkvg"&gt;Commitments &amp;amp; Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The holders of the Founder Shares, Private Placement Units (and their underlying securities), and any Working Capital Loans (up to $&lt;span id="xdx_909_ecustom--WorkingCapitalLoans_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderMember_zz54Lz7OtOHe" title="Working capital loans"&gt;1,500,000&lt;/span&gt;) are entitled to registration rights pursuant to the registration rights agreement signed on the effective date of the IPO, requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule&#160;415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Underwriting Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company granted the underwriters a 45-day option from the effective date of the IPO to purchase up to an additional &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240901__20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z1b6cEmzLyn6" title="Shares granted"&gt;750,000&lt;/span&gt; units to cover over-allotments at the IPO price. On September&#160;13, 2024, the over-allotment options were exercised, generating gross proceeds of $&lt;span id="xdx_909_eus-gaap--ProceedsFromStockOptionsExercised_c20240901__20240913__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zZ7Xk20CRON9" title="Proceeds from stock options exercised"&gt;7,500,000&lt;/span&gt; and deposited into the Trust Account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The underwriters were entitled to an underwriting discount of 4.0% of the gross proceeds of the IPO, of which (i) 1.5% of the gross proceeds of the IPO, or $&lt;span id="xdx_909_eus-gaap--Cash_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zOCaisRK6zX1" title="Cash"&gt;862,500&lt;/span&gt;, were paid in cash at the closing of the IPO, (ii) &lt;span id="xdx_909_eus-gaap--SharesIssued_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RepresentativeSharesMember_zGIsKLTxrQfl" title="Shares issued"&gt;57,500&lt;/span&gt; ordinary shares were paid at the closing of the IPO as representative shares (&#x201c;Representative Shares&#x201d;) (such representative shares shall be registered so as to circumvent reliance on the Rule&#160;144 exemption and shall only therein be subject to FINRA&#x2019;s 180-day lock-up period rule), (iii) 1.0% of the gross proceeds of the IPO, or &lt;span id="xdx_901_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20260101__20260630_zC23qzeg5pwk" title="Gross proceeds of the IPO"&gt;575,000&lt;/span&gt;, will be paid in cash, and &lt;span id="xdx_90F_eus-gaap--SharesIssued_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RepresentativeSharesMember_zG2Nfx2razB9" title="Shares issued"&gt;28,750&lt;/span&gt; representative shares will be issued, both of which as the deferred underwriting commission at the consummation of a Business Combination.&lt;/p&gt;

&lt;p id="xdx_8AC_zjlG5vNKtZD3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

























</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <FVNNU:WorkingCapitalLoans
      contextRef="AsOf2026-06-30_custom_FounderMember"
      decimals="0"
      id="Fact000849"
      unitRef="USD">1500000</FVNNU:WorkingCapitalLoans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2024-09-012024-09-13_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000851"
      unitRef="Shares">750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2024-09-012024-09-13_us-gaap_IPOMember"
      decimals="0"
      id="Fact000853"
      unitRef="USD">7500000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:Cash
      contextRef="AsOf2026-06-30_us-gaap_IPOMember"
      decimals="0"
      id="Fact000855"
      unitRef="USD">862500</us-gaap:Cash>
    <us-gaap:SharesIssued
      contextRef="AsOf2026-06-30_us-gaap_IPOMember_custom_RepresentativeSharesMember"
      decimals="INF"
      id="Fact000857"
      unitRef="Shares">57500</us-gaap:SharesIssued>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000859"
      unitRef="USD">575000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SharesIssued
      contextRef="AsOf2026-06-30_custom_RepresentativeSharesMember"
      decimals="INF"
      id="Fact000861"
      unitRef="Shares">28750</us-gaap:SharesIssued>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000866">&lt;p id="xdx_80C_eus-gaap--SegmentReportingDisclosureTextBlock_zRtdy6ly57R2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 8 &#x2014; &lt;span id="xdx_820_zxlHe4VY4Mf8"&gt;Segment Information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC Topic 280, &#x201c;Segment Reporting,&#x201d; establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company&#x2019;s CODM, or group, in deciding how to allocate resources and assess performance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s CODM has been identified as the Chief Executive Officer, who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that there is only one reportable segment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The CODM assesses performance for the single segment and decides on resource allocation based on the net income or loss reported on the condensed consolidated statements of operations and comprehensive income. The measure of segment assets is reported on the condensed consolidated balance sheet as total assets. When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zMkXwxbn9JAl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Information (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span id="xdx_8BA_zxsejESRmdw7" style="display: none"&gt;Schedule of Segment Information&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20260630_zrdS4MJUGLwf" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20251231_zy9gaNoH9gWb" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--Cash_iI_zaaEjJjRjwYb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 76%; vertical-align: top"&gt;Cash&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;788,401&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,024,709&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--MarketableSecurities_iI_z31GYzO75uP1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Marketable securities held in Trust Account&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;62,882,640&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;61,035,590&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Three Months Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Six Months Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 52%; text-align: left"&gt;Operating expenses&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--OperatingExpenses_c20260401__20260630_zIUfwzdZcdH7" style="text-align: right; width: 9%" title="Operating expenses"&gt;139,769&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--OperatingExpenses_c20250401__20250630_zn3QfDk0ZXHa" style="text-align: right; width: 9%" title="Operating expenses"&gt;70,837&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--OperatingExpenses_c20260101__20260630_zfpDqiR3juW1" style="text-align: right; width: 9%; vertical-align: bottom" title="Operating expenses"&gt;260,972&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--OperatingExpenses_c20250101__20250630_zqoCs9IBAAXg" style="text-align: right; width: 9%; vertical-align: bottom" title="Operating expenses"&gt;237,737&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Income earned on marketable securities held in Trust Account&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;$&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--InterestIncomeExpenseNet_c20260401__20260630_zc7czmcDKxfj" style="text-align: right" title="Operating expenses"&gt;545,639&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;$&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--InterestIncomeExpenseNet_c20250401__20250630_zKI7acnkKfl3" style="text-align: right" title="Operating expenses"&gt;614,436&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;$&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--InterestIncomeExpenseNet_c20260101__20260630_zjuhWy4rGfxa" style="text-align: right; vertical-align: bottom" title="Operating expenses"&gt;1,081,150&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;$&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--InterestIncomeExpenseNet_c20250101__20250630_zvpT9lG8xeqk" style="text-align: right; vertical-align: bottom" title="Operating expenses"&gt;1,226,797&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;






&lt;p id="xdx_8A3_z7ue3KCTKsml" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The CODM reviews income earned on marketable securities held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Operating expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Business Combination period. The CODM also reviews operating expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Operating expenses, as reported on the condensed consolidated statements of operations and comprehensive income, are the significant segment expenses provided to the CODM on a regular basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

















</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000868">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zMkXwxbn9JAl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Information (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span id="xdx_8BA_zxsejESRmdw7" style="display: none"&gt;Schedule of Segment Information&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20260630_zrdS4MJUGLwf" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20251231_zy9gaNoH9gWb" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--Cash_iI_zaaEjJjRjwYb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 76%; vertical-align: top"&gt;Cash&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;788,401&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,024,709&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--MarketableSecurities_iI_z31GYzO75uP1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Marketable securities held in Trust Account&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;62,882,640&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;61,035,590&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Three Months Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;For the&lt;br/&gt; Six Months Ended&lt;br/&gt; June&#160;30,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;(Unaudited)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 52%; text-align: left"&gt;Operating expenses&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--OperatingExpenses_c20260401__20260630_zIUfwzdZcdH7" style="text-align: right; width: 9%" title="Operating expenses"&gt;139,769&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--OperatingExpenses_c20250401__20250630_zn3QfDk0ZXHa" style="text-align: right; width: 9%" title="Operating expenses"&gt;70,837&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--OperatingExpenses_c20260101__20260630_zfpDqiR3juW1" style="text-align: right; width: 9%; vertical-align: bottom" title="Operating expenses"&gt;260,972&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;$&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--OperatingExpenses_c20250101__20250630_zqoCs9IBAAXg" style="text-align: right; width: 9%; vertical-align: bottom" title="Operating expenses"&gt;237,737&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Income earned on marketable securities held in Trust Account&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;$&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--InterestIncomeExpenseNet_c20260401__20260630_zc7czmcDKxfj" style="text-align: right" title="Operating expenses"&gt;545,639&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;$&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--InterestIncomeExpenseNet_c20250401__20250630_zKI7acnkKfl3" style="text-align: right" title="Operating expenses"&gt;614,436&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;$&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--InterestIncomeExpenseNet_c20260101__20260630_zjuhWy4rGfxa" style="text-align: right; vertical-align: bottom" title="Operating expenses"&gt;1,081,150&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;$&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--InterestIncomeExpenseNet_c20250101__20250630_zvpT9lG8xeqk" style="text-align: right; vertical-align: bottom" title="Operating expenses"&gt;1,226,797&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;






</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Cash
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000870"
      unitRef="USD">788401</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000871"
      unitRef="USD">1024709</us-gaap:Cash>
    <us-gaap:MarketableSecurities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000873"
      unitRef="USD">62882640</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000874"
      unitRef="USD">61035590</us-gaap:MarketableSecurities>
    <us-gaap:OperatingExpenses
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000876"
      unitRef="USD">139769</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000878"
      unitRef="USD">70837</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000880"
      unitRef="USD">260972</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000882"
      unitRef="USD">237737</us-gaap:OperatingExpenses>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000884"
      unitRef="USD">545639</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000886"
      unitRef="USD">614436</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000888"
      unitRef="USD">1081150</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000890"
      unitRef="USD">1226797</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000895">&lt;p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zHZR0XUlap9h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 9 &#x2014; &lt;span id="xdx_820_zVUcrnBJgVf2"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluated subsequent events and transactions that occurred after the consolidated balance sheet date through the date of these unaudited condensed consolidated financial statements were issued. Except as disclosed, the Company did not identify any other subsequent events that would require adjustment or disclosure in the condensed consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 8, 2026, in connection with the fifth one-month extension of the deadline to consummate a business combination from July 13, 2026 to August 13, 2026 (the &#x201c;Fifth Extension&#x201d;), the Company issued an unsecured promissory note (the &#x201c;Fifth Extension Promissory Note&#x201d;) to the Sponsor in the principal amount of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20260708__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCZUYrZXlEz6" title="Principal amount"&gt;191,475&lt;/span&gt;. The terms of the Fifth Extension Promissory Note are substantially identical in all material respects to the terms of each of the Extension Promissory Notes, including with respect to interest, maturity, forgiveness upon liquidation, conversion rights, and waiver of claims against the Trust Account. The proceeds of the Fifth Extension Promissory Note were deposited into the Company&#x2019;s Trust Account to fund the Fifth Extension.&lt;/p&gt;



</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-07-08_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact000897"
      unitRef="USD">191475</us-gaap:DebtInstrumentFaceAmount>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="From2026-01-01to2026-06-30" id="Fact000898">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On May 5, 2026, the Company received a written notice (the &#x201c;Notice&#x201d;) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;) indicating that the Company is no longer in compliance with Nasdaq Listing Rule 5550(a)(3) because it failed to maintain a minimum of 300 public holders (the &#x201c;Round Lot Holder Requirement&#x201d;). The Notice is a notification of deficiency, not of imminent delisting, and has &lt;span id="xdx_907_eecd--Rule10b51ArrAdoptedFlag_dbF_c20260101__20260630_zteVO9Yz6gUi"&gt;&lt;span id="xdx_90D_eecd--NonRule10b51ArrAdoptedFlag_dbF_c20260101__20260630_zlDm3cWnu89h"&gt;&lt;span id="xdx_904_eecd--Rule10b51ArrTrmntdFlag_dbF_c20260101__20260630_zsjUeG8szube"&gt;&lt;span id="xdx_906_eecd--NonRule10b51ArrTrmntdFlag_dbF_c20260101__20260630_zTj44ifKhGth"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; current effect on the listing or trading of the Company&#x2019;s ordinary shares on The Nasdaq Capital Market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company is currently evaluating various courses of action to resolve the deficiency and is actively working to develop a plan to regain compliance with the Round Lot Holder Requirement. The Company intends to submit this compliance plan to Nasdaq on or before the June 22, 2026 deadline. If Nasdaq accepts the plan, the Company may be granted an extension of up to 180 calendar days from the date of the Notice to evidence compliance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;While the Company intends to regain compliance, there can be no assurance that Nasdaq will accept the Company&#x2019;s plan or that the Company will be able to satisfy the Round Lot Holder Requirement within the allotted extension period. For additional information regarding the risks associated with this deficiency, please see &#x201c;&lt;i&gt;Part II, Item 1A. Risk Factors&lt;/i&gt;.&#x201d;&lt;/span&gt;&lt;/p&gt; </ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2026-01-01to2026-06-30" id="Fact000899">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2026-01-01to2026-06-30" id="Fact000900">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2026-01-01to2026-06-30" id="Fact000901">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2026-01-01to2026-06-30" id="Fact000902">false</ecd:NonRule10b51ArrTrmntdFlag>
</xbrl>
